{"content":"<li class=\"n-box-item date-title\" data-end=\"1368590399\" data-start=\"1368504000\" data-txt=\"Friday, December 20, 2019\">Tuesday, May 14, 2013</li><li class=\"n-box-item sa-box-item\" data-id=\"1025201\" data-ts=\"1368576233\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MNK\" target=\"_blank\">MNK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1025201\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Questcor Pharmaceuticals (QCOR +13.07%) sits idle in the post session today as the company gets...</a></h4><p>Questcor Pharmaceuticals (QCOR <font color=\"green\">+13.07%</font>) sits idle in the post session today as the company gets its presentation at the BofA/Merrill health-care conference underway. While not likely to provide any sweeping new information, the presentation will paint a clearer picture of what lies ahead for Acthar gel in the realm of an alternative treatment for certain rheumatology-related conditions. According to Janney Montgomery spelling out the numbers of patients needing alternative treatment could what drove some <a href=\"http://www.streetinsider.com/Trader+Talk/Heavily+Shorted+Stocks+Squeeze+Higher+on+Tepper+Blessing/8336314.html\" target=\"_blank\">shorts to cover</a> today. <a href=\"http://www.nasdaq.com/symbol/qcor/short-interest\" target=\"_blank\">Short interest</a> on the stock stands at about 45%.</p><div class=\"tiny-share-widget\" data-id=\"1025201\" data-linked=\"Questcor Pharmaceuticals (QCOR +13.07%) sits idle in the post session today as the company gets...\" data-tweet=\"$MNK - Questcor Pharmaceuticals (QCOR +13.07%) sits idle in the post session today as the company gets its presentation at the BofA/Merrill health-care conference underway. While not likely to provide any sweeping new information, the presentation will ... https://seekingalpha.com/news/1025201?source=tweet\" data-url=\"https://seekingalpha.com/news/1025201\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:03 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1025191\" data-ts=\"1368575588\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/P\" target=\"_blank\">P</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1025191\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pandora (NYSE:P) -3.6% AH following reports Google (NASDAQ:GOOG) will launch subscription-based...</a></h4>Pandora (NYSE:<a href='https://seekingalpha.com/symbol/P' title='Pandora Media'>P</a>) <font color=\"red\">-3.6%</font> AH following <a href=\"https://seekingalpha.com/currents/post/1025171\" target=\"_blank\">reports</a> Google (NASDAQ:<a href='https://seekingalpha.com/symbol/GOOG' title='Alphabet, Inc. Cl C'>GOOG</a>) will launch subscription-based music services - a Spotify-like service, and a YouTube music video service - with at least the former service launching tomorrow. Neither appears to directly compete with Pandora's ad-supported online radio service (which thus far <a href=\"https://seekingalpha.com/currents/post/875421\" target=\"_blank\">hasn't been hurt badly</a> by <a href=\"https://seekingalpha.com/currents/post/705041\" target=\"_blank\">Spotify's growth</a>), particularly given <a href=\"http://www.nytimes.com/2013/05/15/business/media/google-set-to-introduce-music-service-to-compete-with-spotify.html\" target=\"_blank\">an <em>NYT</em> report</a> stating the Spotify-like service won't include a free tier. However, the YouTube service would be a unique market entry, one backed by a site with enormous reach. It would need an audio-only option to keep a lid on battery drain and mobile data usage; <a href=\"http://online.wsj.com/article/SB10001424127887324715704578483542256150334.html\" target=\"_blank\">a <em>WSJ</em> report</a> suggests Google is looking to offer one.<div class=\"tiny-share-widget\" data-id=\"1025191\" data-linked=\"Pandora (NYSE:P) -3.6% AH following reports Google (NASDAQ:GOOG) will launch subscription-based...\" data-tweet=\"$P $P $GOOG - Pandora (NYSE:P) -3.6% AH following reports Google (NASDAQ:GOOG) will launch subscription-based music services - a Spotify-like service, and a YouTube music video service - with at least the former service launching tomorrow. Neither appea... https://seekingalpha.com/news/1025191?source=tweet\" data-url=\"https://seekingalpha.com/news/1025191\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:53 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1025181\" data-ts=\"1368572359\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MYGN\" target=\"_blank\">MYGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1025181\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Myriad Genetics (MYGN +3%) finished the day solidly higher on the back of a New York Times op-ed...</a></h4>Myriad Genetics (<a href='https://seekingalpha.com/symbol/MYGN' title='Myriad Genetics, Inc.'>MYGN</a> <font color=\"green\">+3%</font>) finished the day solidly higher on the back of a <a target=\"_blank\" href=\"http://www.nytimes.com/2013/05/14/opinion/my-medical-choice.html?_r=0\">New York Times op-ed piece</a> by Angelina Jolie outlining her decision to have a double mastectomy after learning she had an 87% chance of developing breast cancer. <a href='https://seekingalpha.com/symbol/MYGN' title='Myriad Genetics, Inc.'>MYGN</a> holds the patent on the test that made the determination, as well as the genes themselves. The test looks for defects in the BRCA1 or BRCA2 genes, which are the cause of most hereditary breast cancer cases.<div class=\"tiny-share-widget\" data-id=\"1025181\" data-linked=\"Myriad Genetics (MYGN +3%) finished the day solidly higher on the back of a New York Times op-ed...\" data-tweet=\"$MYGN - Myriad Genetics (MYGN +3%) finished the day solidly higher on the back of a New York Times op-ed piece by Angelina Jolie outlining her decision to have a double mastectomy after learning she had an 87% chance of developing breast cancer. MYGN ho... https://seekingalpha.com/news/1025181?source=tweet\" data-url=\"https://seekingalpha.com/news/1025181\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:59 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1025111\" data-ts=\"1368569240\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATHX\" target=\"_blank\">ATHX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1025111\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Athersys (NASDAQ:ATHX): Q1 misses on both EPS and revenue as total sales reflected a...</a></h4><p>More on Athersys (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ATHX\" title=\"Athersys, Inc.\">ATHX</a>): <a href=\"https://seekingalpha.com/market_currents/post/1024862\" target=\"_blank\">Q1 misses</a> on both EPS and revenue as total sales reflected a $2.4M decrease in Pfizer contract revenues. Net losses more than doubled over the period, as fair value of warrant liabilities resulted in an expense of $2.6M due to the re-pricing and increases in share price. Shares <font color=\"red\">-3.3%</font> AH.</p><div class=\"tiny-share-widget\" data-id=\"1025111\" data-linked=\"More on Athersys (NASDAQ:ATHX): Q1 misses on both EPS and revenue as total sales reflected a...\" data-tweet=\"$ATHX - More on Athersys (NASDAQ:ATHX): Q1 misses on both EPS and revenue as total sales reflected a $2.4M decrease in Pfizer contract revenues. Net losses more than doubled over the period, as fair value of warrant liabilities resulted in an expense of... https://seekingalpha.com/news/1025111?source=tweet\" data-url=\"https://seekingalpha.com/news/1025111\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:07 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1025022\" data-ts=\"1368566975\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XONE\" target=\"_blank\">XONE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1025022\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on ExOne (NASDAQ:XONE): The company sees FY13 sales coming in between $48M to $52M, below...</a></h4><p>More on ExOne (NASDAQ:<a href=\"https://seekingalpha.com/symbol/XONE\" title=\"ExOne\">XONE</a>): The company sees <a href=\"https://seekingalpha.com/market_currents/post/1024962\" target=\"_blank\">FY13 sales</a> coming in between $48M to $52M, below analysts estimates of $53.25M, citing weakness in Europe which has slowed purchasing decisions of customers in that region. Approximately two-thirds of that sales figure are expected to fall in the latter half of the year. Shares continue to move lower, now <font color=\"red\">-11%</font> AH.</p><div class=\"tiny-share-widget\" data-id=\"1025022\" data-linked=\"More on ExOne (NASDAQ:XONE): The company sees FY13 sales coming in between $48M to $52M, below...\" data-tweet=\"$XONE - More on ExOne (NASDAQ:XONE): The company sees FY13 sales coming in between $48M to $52M, below analysts estimates of $53.25M, citing weakness in Europe which has slowed purchasing decisions of customers in that region. Approximately two-thirds o... https://seekingalpha.com/news/1025022?source=tweet\" data-url=\"https://seekingalpha.com/news/1025022\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1024992\" data-ts=\"1368565797\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XONE\" target=\"_blank\">XONE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1024992\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on ExOne (NASDAQ:XONE): Q1 misses across the board on higher operating expenses. Operating...</a></h4><p>More on ExOne (NASDAQ:<a href=\"https://seekingalpha.com/symbol/XONE\" title=\"ExOne\">XONE</a>): <a href=\"https://seekingalpha.com/market_currents/post/1024962\" target=\"_blank\">Q1 misses</a> across the board on higher operating expenses. Operating losses grew as SG&amp;A expenses rose sharply, primarily as a result of increased professional service fees and the addition of staff to support the company's growth strategy. Margins improved to 35.8% from 30%, due to a favorable sales mix and enhanced productivity in its PSCs. Shares <font color=\"red\">-10.5%</font> AH.</p><div class=\"tiny-share-widget\" data-id=\"1024992\" data-linked=\"More on ExOne (NASDAQ:XONE): Q1 misses across the board on higher operating expenses. Operating...\" data-tweet=\"$XONE - More on ExOne (NASDAQ:XONE): Q1 misses across the board on higher operating expenses. Operating losses grew as SG&amp;A expenses rose sharply, primarily as a result of increased professional service fees and the addition of staff to support the comp... https://seekingalpha.com/news/1024992?source=tweet\" data-url=\"https://seekingalpha.com/news/1024992\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:09 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1024962\" data-ts=\"1368565286\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XONE\" target=\"_blank\">XONE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1024962\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ExOne (NASDAQ:XONE): Q1 EPS loss of $0.20 misses by $0.09. Revenue of $7.9M misses by $1.25M....</a></h4><b>ExOne (NASDAQ:<a href=\"https://seekingalpha.com/symbol/XONE\" title=\"ExOne\">XONE</a>): </b>Q1 EPS loss of $0.20 <font color=\"red\">misses by $0.09</font>. Revenue of $7.9M <font color=\"red\">misses by $1.25M</font>. (PR). Shares <font color=\"red\">-9.5%</font> AH.<div class=\"tiny-share-widget\" data-id=\"1024962\" data-linked=\"ExOne (NASDAQ:XONE): Q1 EPS loss of $0.20 misses by $0.09. Revenue of $7.9M misses by $1.25M....\" data-tweet=\"$XONE - ExOne (NASDAQ:XONE): Q1 EPS loss of $0.20 misses by $0.09. Revenue of $7.9M misses by $1.25M. (PR). Shares -9.5% AH. https://seekingalpha.com/news/1024962?source=tweet\" data-url=\"https://seekingalpha.com/news/1024962\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1024942\" data-ts=\"1368565076\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TXCCQ\" target=\"_blank\">TXCCQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1024942\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TranSwitch (TXCC) +14% AH after announcing (along with its Q1 report) it has hired Needham to...</a></h4><p>TranSwitch (TXCC) <font color=\"green\">+14%</font> AH after announcing (along with its <a target=\"_blank\" href=\"http://finance.yahoo.com/news/transwitch-corporation-announces-first-quarter-202600962.html\">Q1 report</a>) it has <a target=\"_blank\" href=\"http://finance.yahoo.com/news/transwitch-hires-needham-company-evaluate-202800015.html\">hired Needham</a> to evaluate strategic alternatives. Even after factoring the AH gain, the company only has a $17M market cap, easy for a would-be buyer to digest (should one find value in TranSwitch's products and/or IP). Mindspeed, another small-cap telecom chipmaker, announced last month it had <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/983711\">hired Morgan Stanley</a> to do some alternative-evaluating.</p><div class=\"tiny-share-widget\" data-id=\"1024942\" data-linked=\"TranSwitch (TXCC) +14% AH after announcing (along with its Q1 report) it has hired Needham to...\" data-tweet=\"$TXCCQ - TranSwitch (TXCC) +14% AH after announcing (along with its Q1 report) it has hired Needham to evaluate strategic alternatives. Even after factoring the AH gain, the company only has a $17M market cap, easy for a would-be buyer to digest (should... https://seekingalpha.com/news/1024942?source=tweet\" data-url=\"https://seekingalpha.com/news/1024942\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1024812\" data-ts=\"1368562484\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACAD\" target=\"_blank\">ACAD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1024812\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Acadia Pharmaceuticals (NASDAQ:ACAD) announces a public offering. Size and terms of the offering...</a></h4>Acadia Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ACAD' title='ACADIA Pharmaceuticals Inc.'>ACAD</a>) announces a <a href=\"http://www.streetinsider.com/Equity+Offerings/Acadia+Pharmaceuticals+%28ACAD%29+Announces+Stock+Offering/8337102.html\" target=\"_blank\">public offering</a>. Size and terms of the offering weren't disclosed. Jefferies and Cowen are acting as the joint book-running managers for the offering. Shares <font color=\"red\">-5%</font> AH.<div class=\"tiny-share-widget\" data-id=\"1024812\" data-linked=\"Acadia Pharmaceuticals (NASDAQ:ACAD) announces a public offering. Size and terms of the offering...\" data-tweet=\"$ACAD - Acadia Pharmaceuticals (NASDAQ:ACAD) announces a public offering. Size and terms of the offering weren&#39;t disclosed. Jefferies and Cowen are acting as the joint book-running managers for the offering. Shares -5% AH. https://seekingalpha.com/news/1024812?source=tweet\" data-url=\"https://seekingalpha.com/news/1024812\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:14 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1024782\" data-ts=\"1368562077\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RMTI\" target=\"_blank\">RMTI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1024782\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rockwell Medical (NASDAQ:RMTI) announces a public offering, and expects to grant the...</a></h4>Rockwell Medical (NASDAQ:<a href='https://seekingalpha.com/symbol/RMTI' title='Rockwell Medical, Inc.'>RMTI</a>) announces a <a href=\"http://www.streetinsider.com/Equity+Offerings/Rockwell+Medical+%28RMTI%29+Plans+Stock+Offering/8337094.html\" target=\"_blank\">public offering</a>, and expects to grant the underwriters a 30-day option to purchase up to an additional 15% to cover over-allotments, if any. Size and terms of the offering weren't disclosed. Chardan Capital Markets, LLC is acting as the sole book-running manager for the offering. Shares <font color=\"red\">-1.1%</font> AH.<div class=\"tiny-share-widget\" data-id=\"1024782\" data-linked=\"Rockwell Medical (NASDAQ:RMTI) announces a public offering, and expects to grant the...\" data-tweet=\"$RMTI - Rockwell Medical (NASDAQ:RMTI) announces a public offering, and expects to grant the underwriters a 30-day option to purchase up to an additional 15% to cover over-allotments, if any. Size and terms of the offering weren&#39;t disclosed. Chardan Cap... https://seekingalpha.com/news/1024782?source=tweet\" data-url=\"https://seekingalpha.com/news/1024782\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:07 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1024722\" data-ts=\"1368560802\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CPA\" target=\"_blank\">CPA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1024722\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Copa Holdings (CPA +8.3%) trades higher after posting a solid Q1 earnings beat late yesterday....</a></h4>Copa Holdings (<a href='https://seekingalpha.com/symbol/CPA' title='Copa Holdings, S.A.'>CPA</a> <font color=\"green\">+8.3%</font>) trades higher after posting a solid <a target=\"_blank\" href=\"https://seekingalpha.com/market_currents/post/1022441\">Q1 earnings beat</a> late yesterday. Total revenues increased 18.0%, while its bottom line benefited from stronger margins. Yield per passenger mile decreased 0.8%, and operating revenue per available seat mile decreased 1.5%, but when adjusted for a 6.3% increase in length of haul, yields and RASM increased 2.2% and 1.5%, respectively. Deutsche Bank <a target=\"_blank\" href=\"http://www.streetinsider.com/Upgrades/Deutsche+Bank+Upgrades+Copa+Holdings+%28CPA%29+to+Buy/8334111.html\">ups the shares</a> to Buy on the back of the report, and Evercore <a target=\"_blank\" href=\"http://www.streetinsider.com/Upgrades/Evercore+Partners+Upgrades+Copa+Holdings+%28CPA%29+to+Overweight/8334021.html\">raises its rating</a> to Overweight.<div class=\"tiny-share-widget\" data-id=\"1024722\" data-linked=\"Copa Holdings (CPA +8.3%) trades higher after posting a solid Q1 earnings beat late yesterday....\" data-tweet=\"$CPA - Copa Holdings (CPA +8.3%) trades higher after posting a solid Q1 earnings beat late yesterday. Total revenues increased 18.0%, while its bottom line benefited from stronger margins. Yield per passenger mile decreased 0.8%, and operating revenue p... https://seekingalpha.com/news/1024722?source=tweet\" data-url=\"https://seekingalpha.com/news/1024722\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:46 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1024711\" data-ts=\"1368560290\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WPX\" target=\"_blank\">WPX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1024711\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WPX&amp;nbsp;Energy (WPX +2.7%) shares hit a 52-week high before pulling back, extending gains begun...</a></h4>WPX&nbsp;Energy (<a href='https://seekingalpha.com/symbol/WPX' title='WPX Energy, Inc.'>WPX</a> <font color=\"green\">+2.7%</font>) shares <a href=\"http://finance.yahoo.com/news/wpx-energy-shares-continue-rise-160537369.html\" target=\"_blank\">hit a 52-week high</a> before pulling back, extending gains begun after Pennsylvania regulators said their 16-month investigation showed that  high levels of methane and other contaminants in area water wells weren't caused by WPX's drilling. Shares have risen steadily in the weeks since the ruling became public, gaining ~13%.<div class=\"tiny-share-widget\" data-id=\"1024711\" data-linked=\"WPX&amp;nbsp;Energy (WPX +2.7%) shares hit a 52-week high before pulling back, extending gains begun...\" data-tweet=\"$WPX - WPX&amp;nbsp;Energy (WPX +2.7%) shares hit a 52-week high before pulling back, extending gains begun after Pennsylvania regulators said their 16-month investigation showed that high levels of methane and other contaminants in area water wells weren&#39;t... https://seekingalpha.com/news/1024711?source=tweet\" data-url=\"https://seekingalpha.com/news/1024711\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:38 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1024701\" data-ts=\"1368560066\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALIM\" target=\"_blank\">ALIM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1024701\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Alimera Sciences (ALIM +22%) churn higher again today, racking up a +55% run over the...</a></h4>Shares of Alimera Sciences (<a href='https://seekingalpha.com/symbol/ALIM' title='Alimera Sciences, Inc.'>ALIM</a> <font color=\"green\">+22%</font>) churn higher again today, racking up a <font color=\"green\">+55%</font> run over the past three days. The stock has been on the move since announcing in its <a target=\"_blank\" href=\"http://archive.fast-edgar.com/20130510/Aab0-ocnaa9-1Mq-dWf-Ab-0OsbK-l-j/\">10-K</a> that Iluvien had become commercially available in the UK, Germany, France, Spain, Portugal and Austria. Sentiment may also be getting a boost today on a <a target=\"_blank\" href=\"https://seekingalpha.com/article/1428821-alimera-sciences-and-trius-therapeutics-2-big-biotechs-for-2013\">Seeking Alpha article</a> calling the stock an easy double at current levels, and, along with Trius Therapeutics (<a href='https://seekingalpha.com/symbol/TSRX' title=''>TSRX</a> <font color=\"green\">+7.7%</font>), could be one of the biggest gainers in 2013.<div class=\"tiny-share-widget\" data-id=\"1024701\" data-linked=\"Shares of Alimera Sciences (ALIM +22%) churn higher again today, racking up a +55% run over the...\" data-tweet=\"$ALIM $ALIM $MRK - Shares of Alimera Sciences (ALIM +22%) churn higher again today, racking up a +55% run over the past three days. The stock has been on the move since announcing in its 10-K that Iluvien had become commercially available in the UK, Ger... https://seekingalpha.com/news/1024701?source=tweet\" data-url=\"https://seekingalpha.com/news/1024701\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:34 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1024681\" data-ts=\"1368559186\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSL\" target=\"_blank\">TSL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1024681\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nomura sees better days ahead for Trina Solar (TSL -9.7%), even after the company shipped fewer...</a></h4><p>Nomura <a target=\"_blank\" href=\"http://blogs.barrons.com/emergingmarketsdaily/2013/05/14/trina-solar-plunges-9-on-lower-shipments/\">sees better days ahead</a> for Trina Solar (<a href=\"https://seekingalpha.com/symbol/TSL\" title=\"Trina Solar Limited\">TSL</a> <font color=\"red\">-9.7%</font>), even after the company <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/1023231\">shipped fewer modules than forecast</a> and said Q1 gross margins would come in well below the analyst's forecast of 6.2%. Nomura likes TSL's tight cost and raw material inventory control; strong relationships with project developers and utility companies; and net debt of 42% of equity, best among solar companies it covers.</p><div class=\"tiny-share-widget\" data-id=\"1024681\" data-linked=\"Nomura sees better days ahead for Trina Solar (TSL -9.7%), even after the company shipped fewer...\" data-tweet=\"$TSL - Nomura sees better days ahead for Trina Solar (TSL -9.7%), even after the company shipped fewer modules than forecast and said Q1 gross margins would come in well below the analyst&#39;s forecast of 6.2%. Nomura likes TSL&#39;s tight cost and raw materia... https://seekingalpha.com/news/1024681?source=tweet\" data-url=\"https://seekingalpha.com/news/1024681\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:19 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1024671\" data-ts=\"1368558627\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1024671\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tesla Motors (TSLA -3.5%) will make an announcement about its Supercharger Network next week...</a></h4>Tesla Motors (<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a> <font color='red'>-3.5%</font>) will make an <a href=\"https://twitter.com/elonmusk/status/334372943041798144\" target=\"_blank\">announcement</a> about its Supercharger Network next week instead of this week, according to Elon Musk. Shares of Tesla have peeled off a bit of their gaudy gains, but still stand +58% MTD and +151% YTD.<div class=\"tiny-share-widget\" data-id=\"1024671\" data-linked=\"Tesla Motors (TSLA -3.5%) will make an announcement about its Supercharger Network next week...\" data-tweet=\"$TSLA - Tesla Motors (TSLA -3.5%) will make an announcement about its Supercharger Network next week instead of this week, according to Elon Musk. Shares of Tesla have peeled off a bit of their gaudy gains, but still stand +58% MTD and +151% YTD. https://seekingalpha.com/news/1024671?source=tweet\" data-url=\"https://seekingalpha.com/news/1024671\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1024621\" data-ts=\"1368557740\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WRES\" target=\"_blank\">WRES</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1024621\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Warren Resources (WRES +7.2%) pushes higher after a favorable blog post from MBAvalueinvestor...</a></h4><p>Warren Resources (<a href=\"https://seekingalpha.com/symbol/WRES\" title=\"Warren Resources, Inc.\">WRES</a> <font color=\"green\">+7.2%</font>) pushes higher after a <a href=\"https://seekingalpha.com/article/1428431-warren-resources-a-rare-deep-value-e-p-opportunity\" target=\"_blank\">favorable blog post</a> from MBAvalueinvestor highlights the stock, which trades at half the value of its proved reserves and at just 2.6x cash flow. Among other attributes: a low-risk, high-return asset base; fully loaded net asset value provides $2/share-plus of additional upside; potential for an acquisition or upstream spinoff.</p><div class=\"tiny-share-widget\" data-id=\"1024621\" data-linked=\"Warren Resources (WRES +7.2%) pushes higher after a favorable blog post from MBAvalueinvestor...\" data-tweet=\"$WRES - Warren Resources (WRES +7.2%) pushes higher after a favorable blog post from MBAvalueinvestor highlights the stock, which trades at half the value of its proved reserves and at just 2.6x cash flow. Among other attributes: a low-risk, high-return... https://seekingalpha.com/news/1024621?source=tweet\" data-url=\"https://seekingalpha.com/news/1024621\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:55 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1024531\" data-ts=\"1368556999\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HIIQ\" target=\"_blank\">HIIQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1024531\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares in Health Insurance Innovations (HIIQ -15%) tank after reporting a Q1 pre-tax loss of...</a></h4><p>Shares in Health Insurance Innovations (<a href=\"https://seekingalpha.com/symbol/HIIQ\" title=\"Health Insurance Innovations\">HIIQ</a> <font color=\"red\">-15%</font>) tank after reporting a <a target=\"_blank\" href=\"http://www.streetinsider.com/Press+Releases/Health+Insurance+Innovations%2C+Inc.%2C+Reports+First+Quarter+2013+Financial+and+Operating+Results/8333517.html\">Q1 pre-tax loss</a> of $6.3M in comparison to pre-tax income of $0.8M in Q112, due mainly to charges relating to the termination of an accord with TPG. The company also warned of headwinds in FY13, that changes to U.S. health insurance regulations will cause confusion and \"potential disruptive actions\" from competitors. Read more on earnings here: <a target=\"_blank\" href=\"https://seekingalpha.com/article/1433701-health-insurance-innovations-inc-ceo-discusses-q1-2013-results-earnings-call-transcript\">Earnings Call Transcript</a>.</p><div class=\"tiny-share-widget\" data-id=\"1024531\" data-linked=\"Shares in Health Insurance Innovations (HIIQ -15%) tank after reporting a Q1 pre-tax loss of...\" data-tweet=\"$HIIQ - Shares in Health Insurance Innovations (HIIQ -15%) tank after reporting a Q1 pre-tax loss of $6.3M in comparison to pre-tax income of $0.8M in Q112, due mainly to charges relating to the termination of an accord with TPG. The company also warned... https://seekingalpha.com/news/1024531?source=tweet\" data-url=\"https://seekingalpha.com/news/1024531\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:43 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1024511\" data-ts=\"1368556567\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1024511\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apple (AAPL -2.5%) has dived over the last 30 minutes of trading on heavy volume, without any...</a></h4>Apple (<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a> <font color='red'>-2.5%</font>) has dived over the last 30 minutes of trading on <a href=\"http://finance.yahoo.com/q/bc?s=AAPL+Basic+Chart&amp;t=1d\" target=\"_blank\">heavy volume</a>, without any news to explain the move. The decline comes with the NASDAQ still up 0.5% on the day.<div class=\"tiny-share-widget\" data-id=\"1024511\" data-linked=\"Apple (AAPL -2.5%) has dived over the last 30 minutes of trading on heavy volume, without any...\" data-tweet=\"$AAPL - Apple (AAPL -2.5%) has dived over the last 30 minutes of trading on heavy volume, without any news to explain the move. The decline comes with the NASDAQ still up 0.5% on the day. https://seekingalpha.com/news/1024511?source=tweet\" data-url=\"https://seekingalpha.com/news/1024511\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>74&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1024481\" data-ts=\"1368555839\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IOC\" target=\"_blank\">IOC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1024481\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">InterOil (IOC +12.1%) is reiterated with an Outperform rating and $100 price target by Raymond...</a></h4><p>InterOil (<a href=\"https://seekingalpha.com/symbol/IOC\" title=\"InterOil Corporation\">IOC</a> <font color=\"green\">+12.1%</font>) is reiterated with an <a target=\"_blank\" href=\"http://www.streetinsider.com/Analyst+Comments/InterOil+%28IOC%29+Q1+Uneventful%2C+But+Shares+Poised+to+Move+Higher+-+Raymond+James/8335960.html\">Outperform rating</a> and $100 price target by Raymond James even though <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/1023931\">Q1 results</a> were \"uneventful.\" The firm says investors should focus on IOC's long-term cash flow potential and multiple upcoming catalysts, including a much-anticipated LNG partnership with an international company, presumably incorporating a resource selldown.</p><div class=\"tiny-share-widget\" data-id=\"1024481\" data-linked=\"InterOil (IOC +12.1%) is reiterated with an Outperform rating and $100 price target by Raymond...\" data-tweet=\"$IOC - InterOil (IOC +12.1%) is reiterated with an Outperform rating and $100 price target by Raymond James even though Q1 results were &quot;uneventful.&quot; The firm says investors should focus on IOC&#39;s long-term cash flow potential and multiple upcoming catal... https://seekingalpha.com/news/1024481?source=tweet\" data-url=\"https://seekingalpha.com/news/1024481\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1024471\" data-ts=\"1368555414\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HIMX\" target=\"_blank\">HIMX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1024471\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Himax (HIMX +7.3%) is shooting higher yet again, and is close to its 52-week high of $7.10. SA...</a></h4><p>Himax (<a href=\"https://seekingalpha.com/symbol/HIMX\" title=\"Himax Technologies, Inc.\">HIMX</a> <font color=\"green\">+7.3%</font>) is shooting higher yet again, and is close to its 52-week high of $7.10. SA contributor <a href=\"https://seekingalpha.com/article/1432191-himax-shares-set-to-soar\" target=\"_blank\">Proprietary Trading</a> has made a bull case that declares the adoption of <a href=\"https://seekingalpha.com/currents/post/567001\" target=\"_blank\">higher-resolution</a> smartphone/tablet displays represents a major growth opportunity for the company, thanks to its <a href=\"https://seekingalpha.com/currents/post/1004931\" target=\"_blank\">growing mobile driver IC ops</a>. Investor attention has been focused more on Himax's <a href=\"http://www.himaxdisplay.com/en/product/info.asp\" target=\"_blank\">LCOS microdisplay</a> business (and a possible <a href=\"https://seekingalpha.com/currents/post/873551\" target=\"_blank\">Google Glass design win</a>).</p><div class=\"tiny-share-widget\" data-id=\"1024471\" data-linked=\"Himax (HIMX +7.3%) is shooting higher yet again, and is close to its 52-week high of $7.10. SA...\" data-tweet=\"$HIMX - Himax (HIMX +7.3%) is shooting higher yet again, and is close to its 52-week high of $7.10. SA contributor Proprietary Trading has made a bull case that declares the adoption of higher-resolution smartphone/tablet displays represents a major gro... https://seekingalpha.com/news/1024471?source=tweet\" data-url=\"https://seekingalpha.com/news/1024471\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1024461\" data-ts=\"1368555328\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEVA\" target=\"_blank\">TEVA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1024461\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NuPathe (PATH -2.4%) slides after posting a Q1 loss of $0.21 per share earlier today, versus the...</a></h4><p>NuPathe (<a href=\"https://seekingalpha.com/symbol/PATH\" title=\"\">PATH</a> <font color=\"red\">-2.4%</font>) slides after posting a Q1 loss of $0.21 per share earlier today, versus the consensus loss of $0.19 per share. The company did not record revenues for the quarter, as expected. The miss can be attributed to dilution stemming from the automatic conversion of its Series A Preferred Stock, which was triggered in February, resulting in the conversion of 100% of the outstanding into common stock, as well as the termination of a \"full ratchet\" anti-dilution feature on warrants issued in connection with the preferred stock in October 2012.</p><div class=\"tiny-share-widget\" data-id=\"1024461\" data-linked=\"NuPathe (PATH -2.4%) slides after posting a Q1 loss of $0.21 per share earlier today, versus the...\" data-tweet=\"$TEVA - NuPathe (PATH -2.4%) slides after posting a Q1 loss of $0.21 per share earlier today, versus the consensus loss of $0.19 per share. The company did not record revenues for the quarter, as expected. The miss can be attributed to dilution stemming... https://seekingalpha.com/news/1024461?source=tweet\" data-url=\"https://seekingalpha.com/news/1024461\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1024431\" data-ts=\"1368554407\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VRML\" target=\"_blank\">VRML</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1024431\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vermillion (VRML -2.3%) reverses earlier gains to trade lower today, after saying VRML), a...</a></h4><p>Vermillion (<a href=\"https://seekingalpha.com/symbol/VRML\" title=\"Vermillion, Inc.\">VRML</a> <font color=\"red\">-2.3%</font>) reverses earlier gains to trade lower today, after saying <a href=\"https://seekingalpha.com/symbol/VRML\" title=\"Vermillion, Inc.\">VRML</a>), a molecular diagnostics company focused on gynecologic cancers and womens' health, is up 4% in early trading after it says it has closed a previously announced private placement through which 8.0 million shares of its shares were bought.\" target=\"_blank\"&gt;it's closed its 8M share private placement, with net proceeds of $11.8M after expenses. The company also issued warrants for 12.5M shares of stock at $1.46 per share, which could give <a href=\"https://seekingalpha.com/symbol/VRML\" title=\"Vermillion, Inc.\">VRML</a> an additional $18.3M in proceeds, bringing the total gross proceeds to $31.5M.</p><div class=\"tiny-share-widget\" data-id=\"1024431\" data-linked=\"Vermillion (VRML -2.3%) reverses earlier gains to trade lower today, after saying VRML), a...\" data-tweet=\"$VRML - Vermillion (VRML -2.3%) reverses earlier gains to trade lower today, after saying VRML), a molecular diagnostics company focused on gynecologic cancers and womens&#39; health, is up 4% in early trading after it says it has closed a previously announ... https://seekingalpha.com/news/1024431?source=tweet\" data-url=\"https://seekingalpha.com/news/1024431\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1024411\" data-ts=\"1368553855\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VVUS\" target=\"_blank\">VVUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1024411\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vivus (VVUS +1.9%) continues to trade higher this week on hopes the company may partner with Big...</a></h4><p>Vivus (<a href=\"https://seekingalpha.com/symbol/VVUS\" title=\"Vivus, Inc.\">VVUS</a> <font color=\"green\">+1.9%</font>) continues to trade higher this week on hopes the company may partner with Big Pharma to expand access to the obesity drug Qsymia (<a href=\"https://seekingalpha.com/currents/post/1020511\" target=\"_blank\">I</a>, <a href=\"https://seekingalpha.com/currents/post/1009741\" target=\"_blank\">II</a>). Nevertheless, some, like Lazard's Joshua Schimmer, say the reality is that demand for the drug has so far proven tepid and VVUS \"needs to find commercial success \u2026 or significantly reduce costs in order to slow the current cash outflow\" \u2014 operating expenses rose 208% Y/Y in Q1. Lazard <a href=\"http://www.benzinga.com/analyst-ratings/downgrades/13/05/3588514/vivus-downgraded-earlier-by-lazard-on-news-of-poorly-perfor\" target=\"_blank\">downgrades the shares</a> to Neutral from Buy.</p><div class=\"tiny-share-widget\" data-id=\"1024411\" data-linked=\"Vivus (VVUS +1.9%) continues to trade higher this week on hopes the company may partner with Big...\" data-tweet=\"$VVUS - Vivus (VVUS +1.9%) continues to trade higher this week on hopes the company may partner with Big Pharma to expand access to the obesity drug Qsymia (I, II). Nevertheless, some, like Lazard&#39;s Joshua Schimmer, say the reality is that demand for th... https://seekingalpha.com/news/1024411?source=tweet\" data-url=\"https://seekingalpha.com/news/1024411\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:50 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1024381\" data-ts=\"1368552549\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AGN\" target=\"_blank\">AGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1024381\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Actavis (ACT +1.2%) spikes on reports that the company recently turned away a $15B bid from...</a></h4>Actavis (<a href='https://seekingalpha.com/symbol/ACT' title='AdvisorShares Vice ETF'>ACT</a> <font color=\"green\">+1.2%</font>) spikes on reports that the company <a target=\"_blank\" href=\"http://www.streetinsider.com/Rumors/Actavis+%28ACT%29+said+to+have+turned+away+%2415+billion+bid+from+Mylan+%28MYL%29+-+Bloomberg/8336201.html\">recently turned away</a> a $15B bid from Mylan (<a href='https://seekingalpha.com/symbol/MYL' title='Mylan Inc'>MYL</a> <font color=\"green\">+0.1%</font>).<div class=\"tiny-share-widget\" data-id=\"1024381\" data-linked=\"Actavis (ACT +1.2%) spikes on reports that the company recently turned away a $15B bid from...\" data-tweet=\"$AGN $AGN $MYL - Actavis (ACT +1.2%) spikes on reports that the company recently turned away a $15B bid from Mylan (MYL +0.1%). https://seekingalpha.com/news/1024381?source=tweet\" data-url=\"https://seekingalpha.com/news/1024381\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:29 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1024361\" data-ts=\"1368552159\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACUR\" target=\"_blank\">ACUR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1024361\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Roth initiates Acura Pharmaceuticals (OTC:ACUR +5.8%) at Buy with a $4.50 price target,...</a></h4><p>Roth <a href=\"http://www.streetinsider.com/New+Coverage/Roth+Capital+Starts+Acura+Pharmaceuticals+%28ACUR%29+at+Buy/8334649.html\" target=\"_blank\">initiates</a> Acura Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/ACUR\" title=\"Acura Pharmaceuticals, Inc.\">OTC:ACUR</a> <font color=\"green\">+5.8%</font>) at Buy with a $4.50 price target, representing a near 100% upside from Monday's closing price. On the <a href=\"https://seekingalpha.com/article/1400511-acura-pharmaceuticals-management-discusses-q1-2013-results-earnings-call-transcript\" target=\"_blank\">earnings call</a> earlier this month, Roth analyst Robert Cummins Hazlett had a good-natured back-and-forth with management regarding NEXAFED and OXECTA.</p><div class=\"tiny-share-widget\" data-id=\"1024361\" data-linked=\"Roth initiates Acura Pharmaceuticals (OTC:ACUR +5.8%) at Buy with a $4.50 price target,...\" data-tweet=\"$ACUR - Roth initiates Acura Pharmaceuticals (OTC:ACUR +5.8%) at Buy with a $4.50 price target, representing a near 100% upside from Monday&#39;s closing price. On the earnings call earlier this month, Roth analyst Robert Cummins Hazlett had a good-natured ... https://seekingalpha.com/news/1024361?source=tweet\" data-url=\"https://seekingalpha.com/news/1024361\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1024351\" data-ts=\"1368551993\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSL\" target=\"_blank\">TSL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1024351\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ever-volatile Chinese solar stocks slide after Trina (TSL -8.3%) slashes its Q1 module shipment...</a></h4>Ever-volatile Chinese solar stocks slide after Trina (<a href='https://seekingalpha.com/symbol/TSL' title='Trina Solar Limited'>TSL</a> <font color='red'>-8.3%</font>) <a href=\"https://seekingalpha.com/currents/post/1023231\" target=\"_blank\">slashes its Q1 module shipment guidance</a> and forecasts a gross margin for the quarter of just 1%-3%. <a href='https://seekingalpha.com/symbol/DQ' title='DAQO New Energy Corp.'>DQ</a> <font color=\"red\">-5.9%</font>. <a href='https://seekingalpha.com/symbol/JKS' title='JinkoSolar Holding Co., Ltd.'>JKS</a> <font color=\"red\">-5.9%</font>. <a href='https://seekingalpha.com/symbol/YGE' title='Yingli Green Energy Holding Company Limited'>YGE</a> <font color=\"red\">-5.1%</font>. <a href='https://seekingalpha.com/symbol/LDK' title='LDK Solar Co., Ltd.'>LDK</a> <font color=\"red\">-4.8%</font>. <a href='https://seekingalpha.com/symbol/SOL' title='ReneSola Ltd.'>SOL</a> <font color=\"red\">-3.6%</font>. <a href='https://seekingalpha.com/symbol/JASO' title='JA Solar Holdings, Co., Ltd.'>JASO</a> <font color=\"red\">-2.2%</font>. U.S. solar installer/electricity seller SolarCity delivered <a href=\"https://seekingalpha.com/currents/post/1022181\" target=\"_blank\">mixed Q1 results</a> and reiterated its full-year guidance yesterday afternoon. (<a href=\"https://seekingalpha.com/currents/post/1021301\" target=\"_blank\">yesterday's gains</a>)<div class=\"tiny-share-widget\" data-id=\"1024351\" data-linked=\"Ever-volatile Chinese solar stocks slide after Trina (TSL -8.3%) slashes its Q1 module shipment...\" data-tweet=\"$TSL $TSL $DQ - Ever-volatile Chinese solar stocks slide after Trina (TSL -8.3%) slashes its Q1 module shipment guidance and forecasts a gross margin for the quarter of just 1%-3%. DQ -5.9%. JKS -5.9%. YGE -5.1%. LDK -4.8%. SOL -3.6%. JASO -2.2%. U.S. s... https://seekingalpha.com/news/1024351?source=tweet\" data-url=\"https://seekingalpha.com/news/1024351\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:19 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1024321\" data-ts=\"1368551438\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DYNT\" target=\"_blank\">DYNT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1024321\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares in Dynatronics Corporation (DYNT -4.8%) take a hit today after posting an FQ3 net loss of...</a></h4><p>Shares in Dynatronics Corporation (<a href=\"https://seekingalpha.com/symbol/DYNT\" title=\"Dynatronics Corporation\">DYNT</a> <font color=\"red\">-4.8%</font>) take a hit today after posting an FQ3 net loss of $0.02 per share, which was actually much better when compared to the same quarter in the prior fiscal year, due largely to a decline in operating expenses. Q3 sales declined however, by 7.6% to $7.07M, compared to $7.65 in Q312. The company cites lower sales of distributed products, medical supplies and consumable products used by clinics for the decline.</p><div class=\"tiny-share-widget\" data-id=\"1024321\" data-linked=\"Shares in Dynatronics Corporation (DYNT -4.8%) take a hit today after posting an FQ3 net loss of...\" data-tweet=\"$DYNT - Shares in Dynatronics Corporation (DYNT -4.8%) take a hit today after posting an FQ3 net loss of $0.02 per share, which was actually much better when compared to the same quarter in the prior fiscal year, due largely to a decline in operating ex... https://seekingalpha.com/news/1024321?source=tweet\" data-url=\"https://seekingalpha.com/news/1024321\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:10 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1024281\" data-ts=\"1368550936\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FIVE\" target=\"_blank\">FIVE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1024281\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Retailer Five Below (FIVE +3.1%) jumps after saying sales grew 33% and comps rose 4.2% in Q1....</a></h4><p>Retailer Five Below (<a href=\"https://seekingalpha.com/symbol/FIVE\" title=\"Five Below\">FIVE</a> <font color=\"green\">+3.1%</font>) jumps after saying sales grew 33% and comps rose 4.2% in Q1. CEO Thomas Vellios says headwinds \"began to dissipate\" halfway through the quarter and both \"traffic and sales trends\" strengthened. In light of the results, the company raises its Q1 adjusted EPS outlook to $0.03-0.04 per share from $0.02-0.03 per share previously. (PR)</p><div class=\"tiny-share-widget\" data-id=\"1024281\" data-linked=\"Retailer Five Below (FIVE +3.1%) jumps after saying sales grew 33% and comps rose 4.2% in Q1....\" data-tweet=\"$FIVE - Retailer Five Below (FIVE +3.1%) jumps after saying sales grew 33% and comps rose 4.2% in Q1. CEO Thomas Vellios says headwinds &quot;began to dissipate&quot; halfway through the quarter and both &quot;traffic and sales trends&quot; strengthened. In light of the re... https://seekingalpha.com/news/1024281?source=tweet\" data-url=\"https://seekingalpha.com/news/1024281\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1024271\" data-ts=\"1368550878\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACER\" target=\"_blank\">ACER</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1024271\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Opexa (OPXA -18%) gets slammed today after posting a Q1 net loss of $0.58 per share,...</a></h4><p>Opexa (OPXA <font color=\"red\">-18%</font>) gets slammed today after posting a Q1 net loss of $0.58 per share, significantly wider than a year-ago, as operating expenses climbed. The company did manage to record $220K in revenue as part of its upfront payments from Merck Serono, versus no revenue during the year-ago quarter. There were no analyst estimates available for comparison.</p><div class=\"tiny-share-widget\" data-id=\"1024271\" data-linked=\"Opexa (OPXA -18%) gets slammed today after posting a Q1 net loss of $0.58 per share,...\" data-tweet=\"$ACER - Opexa (OPXA -18%) gets slammed today after posting a Q1 net loss of $0.58 per share, significantly wider than a year-ago, as operating expenses climbed. The company did manage to record $220K in revenue as part of its upfront payments from Merck... https://seekingalpha.com/news/1024271?source=tweet\" data-url=\"https://seekingalpha.com/news/1024271\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1024221\" data-ts=\"1368550269\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBLI\" target=\"_blank\">CBLI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1024221\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cleveland BioLabs (CBLI +3.3%) gains today after saying that it and Incuron, a joint venture...</a></h4><p>Cleveland BioLabs (<a href=\"https://seekingalpha.com/symbol/CBLI\" title=\"Cleveland BioLabs, Inc.\">CBLI</a> <font color=\"green\">+3.3%</font>) gains today after saying that it and Incuron, a joint venture between the company and Bioprocess Capital Ventures, have received patent approval from the USPTO for Curaxin. The European Patent Office also signed off on a patent for New Zealand, South Africa, and Kazhakstan recently, while the Russian Federation issued one as well.</p><div class=\"tiny-share-widget\" data-id=\"1024221\" data-linked=\"Cleveland BioLabs (CBLI +3.3%) gains today after saying that it and Incuron, a joint venture...\" data-tweet=\"$CBLI - Cleveland BioLabs (CBLI +3.3%) gains today after saying that it and Incuron, a joint venture between the company and Bioprocess Capital Ventures, have received patent approval from the USPTO for Curaxin. The European Patent Office also signed of... https://seekingalpha.com/news/1024221?source=tweet\" data-url=\"https://seekingalpha.com/news/1024221\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:51 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1024191\" data-ts=\"1368549918\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IDXG\" target=\"_blank\">IDXG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1024191\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday top 10 gainers: PDII +31%. UNTK +22%. ALIM +19%. SODA +15%. CHLN +15%. TEAR +14%. ESI-OLD...</a></h4><b>Midday top 10 gainers:</b> PDII <font color=\"green\">+31%</font>. <a href='https://seekingalpha.com/symbol/UNTK' title='UniTek Global Services Inc.'>UNTK</a> <font color=\"green\">+22%</font>. <a href='https://seekingalpha.com/symbol/ALIM' title='Alimera Sciences, Inc.'>ALIM</a> <font color=\"green\">+19%</font>. <a href='https://seekingalpha.com/symbol/SODA' title='SodaStream International'>SODA</a> <font color=\"green\">+15%</font>. <a href='https://seekingalpha.com/symbol/CHLN' title='China Housing & Land Development, Inc.'>CHLN</a> <font color=\"green\">+15%</font>. <a href='https://seekingalpha.com/symbol/TEAR' title='TearLab Corporation'>TEAR</a> <font color=\"green\">+14%</font>. <a href='https://seekingalpha.com/symbol/ESI-OLD' title='ITT Educational Services Inc.'>ESI-OLD</a> <font color=\"green\">+14%</font>. ECTY <font color=\"green\">+14%</font>. <a href='https://seekingalpha.com/symbol/BVSN' title='BroadVision, Inc.'>BVSN</a> <font color=\"green\">+12%</font>. <a href='https://seekingalpha.com/symbol/RVLT' title='Revolution Lighting Technologies, Inc.'>RVLT</a> 12%.<br /> <b>Midday top 10 losers:</b> <a href='https://seekingalpha.com/symbol/TELOZ' title='TEL Offshore Trust'>OTCPK:TELOZ</a> <font color=\"red\">-28%</font>. OPXA <font color=\"red\">-19%</font>. <a href='https://seekingalpha.com/symbol/SED' title='SED International Holdings, Inc.'>SED</a> <font color=\"red\">-16%</font>. <a href='https://seekingalpha.com/symbol/STXS' title='Stereotaxis, Inc.'>STXS</a> <font color=\"red\">-14%</font>. FMAR <font color=\"red\">-13%</font>. <a href='https://seekingalpha.com/symbol/VELT' title=''>VELT</a> <font color=\"red\">-12%</font>. <a href='https://seekingalpha.com/symbol/TSRE' title='Trade Street Residential, Inc.'>TSRE</a> <font color=\"red\">-12%</font>. <a href='https://seekingalpha.com/symbol/TRMD-OLD' title='Steamship Co. Torm A/S'>TRMD-OLD</a> <font color=\"red\">-11%</font>. <a href='https://seekingalpha.com/symbol/CCCL' title='China Ceramics Co., Ltd.'>CCCL</a> <font color=\"red\">-10%</font>. <a href='https://seekingalpha.com/symbol/PT-OLD' title='Portugal Telecom SGPS SA'>PT-OLD</a> <font color=\"red\">-10%</font>.<div class=\"tiny-share-widget\" data-id=\"1024191\" data-linked=\"Midday top 10 gainers: PDII +31%. UNTK +22%. ALIM +19%. SODA +15%. CHLN +15%. TEAR +14%. ESI-OLD...\" data-tweet=\"$IDXG $IDXG $UNTK - Midday top 10 gainers: PDII +31%. UNTK +22%. ALIM +19%. SODA +15%. CHLN +15%. TEAR +14%. ESI-OLD +14%. ECTY +14%. BVSN +12%. RVLT 12%. Midday top 10 losers: OTCPK:TELOZ -28%. OPXA -19%. SED -16%. STXS -14%. FMAR -13%. VELT -12%. TSRE... https://seekingalpha.com/news/1024191?source=tweet\" data-url=\"https://seekingalpha.com/news/1024191\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:45 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1024171\" data-ts=\"1368549791\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SHW\" target=\"_blank\">SHW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1024171\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Valspar&#39;s (VAL +4.4%) FQ2: Paint sales rise 3% Y/Y on North American volume growth while...</a></h4><p>More on Valspar's (VAL <font color=\"green\">+4.4%</font>) <a href=\"https://seekingalpha.com/currents/post/1023051\" target=\"_blank\">FQ2</a>: Paint sales rise 3% Y/Y on North American volume growth while EBIT margins within the segment increase 100 basis points. Sales and margins within the coatings segment fall 1% and 110 basis points respectively, on lower demand for the industrial product line. VAL will take restructuring charges of $18-23M across FY13 and FY14 which, along with other measures, will result in annual savings of ~$0.10 per share from 2015 forward. FY13 EPS guidance is reaffirmed at $3.60-3.80 (consensus is $3.68). (PR)</p><div class=\"tiny-share-widget\" data-id=\"1024171\" data-linked=\"More on Valspar&#39;s (VAL +4.4%) FQ2: Paint sales rise 3% Y/Y on North American volume growth while...\" data-tweet=\"$SHW - More on Valspar&#39;s (VAL +4.4%) FQ2: Paint sales rise 3% Y/Y on North American volume growth while EBIT margins within the segment increase 100 basis points. Sales and margins within the coatings segment fall 1% and 110 basis points respectively, o... https://seekingalpha.com/news/1024171?source=tweet\" data-url=\"https://seekingalpha.com/news/1024171\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:43 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1024141\" data-ts=\"1368549175\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOL\" target=\"_blank\">GOL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1024141\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gol Linhas (GOL +3%) moves up today, in spite of posting a wider Q1 loss due to a drop in...</a></h4><p>Gol Linhas (<a href=\"https://seekingalpha.com/symbol/GOL\" title=\"GOL Linhas Aéreas Inteligentes S.A.\">GOL</a> <font color=\"green\">+3%</font>) moves up today, in spite of posting a wider Q1 loss due to a drop in revenue and an increase in debt service costs. The company reported a net loss of BRL75.3M ($37.65M) for the quarter, compared with a loss of BRL41.4 million in the same period a year earlier. Net revenue fell 3.8% to BRL2.08B, while debt service costs totaled BRL106.9M, up from BRL23.2M in Q112. Operating expenses dropped 8.2% to BRL1.98B, however, operating margin jumped to 4.9%, an increase of 4.6% over Q112's 0.3%.</p><div class=\"tiny-share-widget\" data-id=\"1024141\" data-linked=\"Gol Linhas (GOL +3%) moves up today, in spite of posting a wider Q1 loss due to a drop in...\" data-tweet=\"$GOL - Gol Linhas (GOL +3%) moves up today, in spite of posting a wider Q1 loss due to a drop in revenue and an increase in debt service costs. The company reported a net loss of BRL75.3M ($37.65M) for the quarter, compared with a loss of BRL41.4 millio... https://seekingalpha.com/news/1024141?source=tweet\" data-url=\"https://seekingalpha.com/news/1024141\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:32 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1024101\" data-ts=\"1368548717\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1024101\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Credit Suisse and Roth downgrade SolarCity (SCTY -2.5%) following its mixed Q1 results and 2013...</a></h4><p>Credit Suisse and Roth downgrade SolarCity (SCTY <font color=\"red\">-2.5%</font>) following its <a href=\"https://seekingalpha.com/currents/post/1022181\" target=\"_blank\">mixed Q1 results</a> and 2013 guidance reiteration. Nonetheless, shares are giving back less than 1/9 of yesterday's huge gains. Roth, <a href=\"http://blogs.barrons.com/techtraderdaily/2013/05/14/this-morning-blackberry-eyes-women-shield-arrives-cheers-for-fio-yhoo/\" target=\"_blank\">cutting shares to Neutral</a>, cites a 350% post-IPO gain, 10% system-funding costs, and a potentially unsustainable 2.9% pricing \"escalator\" for electricity contracts as reasons to be concerned. Though SolarCity's Q2 revenue guidance is well below consensus, deployments are expected to grow to 48MW-53MW from Q1's 46MW. On the <a href=\"https://seekingalpha.com/article/1431831-solarcity-s-ceo-discusses-q1-2013-results-earnings-call-transcript\" target=\"_blank\">earnings call</a>, COO Peter Rive stated SolarCity remains \"delivery constrained,\" and is scaling its residential ops in response.</p><div class=\"tiny-share-widget\" data-id=\"1024101\" data-linked=\"Credit Suisse and Roth downgrade SolarCity (SCTY -2.5%) following its mixed Q1 results and 2013...\" data-tweet=\"$TSLA - Credit Suisse and Roth downgrade SolarCity (SCTY -2.5%) following its mixed Q1 results and 2013 guidance reiteration. Nonetheless, shares are giving back less than 1/9 of yesterday&#39;s huge gains. Roth, cutting shares to Neutral, cites a 350% post... https://seekingalpha.com/news/1024101?source=tweet\" data-url=\"https://seekingalpha.com/news/1024101\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1024081\" data-ts=\"1368548345\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LVS\" target=\"_blank\">LVS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1024081\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Las Vegas Sands (LVS +2%) gets a lift from BofA analyst Shaun Kelley who says the company&#39;s...</a></h4>Las Vegas Sands (<a href='https://seekingalpha.com/symbol/LVS' title='Las Vegas Sands Corp.'>LVS</a> <font color=\"green\">+2%</font>) gets a lift from BofA analyst Shaun Kelley who says the company's Asian real estate holdings are worth $5-7 per share in a spinoff. Kelley also claims LVS is under levered, could afford to double its debt, and <a target=\"_blank\" href=\"http://www.benzinga.com/analyst-ratings/analyst-color/13/05/3588157/las-vegas-sands-shares-higher-as-bofa-says-co-should-spi\">may be worth $82</a> per share. (See also: Nomura <a target=\"_blank\" href=\"https://seekingalpha.com/symbol/lvs/currents\">ups targets</a> on gaming stocks)<div class=\"tiny-share-widget\" data-id=\"1024081\" data-linked=\"Las Vegas Sands (LVS +2%) gets a lift from BofA analyst Shaun Kelley who says the company&#39;s...\" data-tweet=\"$LVS - Las Vegas Sands (LVS +2%) gets a lift from BofA analyst Shaun Kelley who says the company&#39;s Asian real estate holdings are worth $5-7 per share in a spinoff. Kelley also claims LVS is under levered, could afford to double its debt, and may be wor... https://seekingalpha.com/news/1024081?source=tweet\" data-url=\"https://seekingalpha.com/news/1024081\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1024051\" data-ts=\"1368547998\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IVC\" target=\"_blank\">IVC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1024051\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Invacare (IVC +8.4%) pops after the FDA accepts the results of its first certification audit...</a></h4><p>Invacare (<a href=\"https://seekingalpha.com/symbol/IVC\" title=\"Invacare Corporation\">IVC</a> <font color=\"green\">+8.4%</font>) pops after the FDA accepts the results of its first certification audit relating to qualification and validation documentation for equipment and processes at its manufacturing facility in Elyria, Ohio. With the FDA's go-ahead, the facility - which is currently subject to limitations on production due to an FDA consent decree - may now resume manufacturing and distribution to <a href=\"https://seekingalpha.com/symbol/IVC\" title=\"Invacare Corporation\">IVC</a> facilities beyond just its Taylor Street or corporate facilities.</p><div class=\"tiny-share-widget\" data-id=\"1024051\" data-linked=\"Invacare (IVC +8.4%) pops after the FDA accepts the results of its first certification audit...\" data-tweet=\"$IVC - Invacare (IVC +8.4%) pops after the FDA accepts the results of its first certification audit relating to qualification and validation documentation for equipment and processes at its manufacturing facility in Elyria, Ohio. With the FDA&#39;s go-ahead... https://seekingalpha.com/news/1024051?source=tweet\" data-url=\"https://seekingalpha.com/news/1024051\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:13 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1023981\" data-ts=\"1368545987\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MRK\" target=\"_blank\">MRK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1023981\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Trius Therapeutics (TSRX +5.6%) gain this morning after the company announced late...</a></h4><p>Shares of Trius Therapeutics (<a href=\"https://seekingalpha.com/symbol/TSRX\" title=\"\">TSRX</a> <font color=\"green\">+5.6%</font>) gain this morning after the company announced late yesterday that it's received a Notice of Allowance from the USPTO on an application related to its tedizolid phosphate patent portfolio. The new application protects a therapeutic combination of the experimental medicine with a currently available antibiotic daptomycin. Together, <a href=\"https://seekingalpha.com/symbol/TSRX\" title=\"\">TSRX</a> claims the medicines can prevent the development of certain strains of staph infection.</p><div class=\"tiny-share-widget\" data-id=\"1023981\" data-linked=\"Shares of Trius Therapeutics (TSRX +5.6%) gain this morning after the company announced late...\" data-tweet=\"$MRK - Shares of Trius Therapeutics (TSRX +5.6%) gain this morning after the company announced late yesterday that it&#39;s received a Notice of Allowance from the USPTO on an application related to its tedizolid phosphate patent portfolio. The new applicat... https://seekingalpha.com/news/1023981?source=tweet\" data-url=\"https://seekingalpha.com/news/1023981\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:39 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1023951\" data-ts=\"1368545495\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BB\" target=\"_blank\">BB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1023951\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BlackBerry Messenger is coming to iOS and Android this summer, BlackBerry (BBRY -4.5%) announces...</a></h4><p>BlackBerry Messenger is <a href=\"http://finance.yahoo.com/news/bbm-ios-android-launch-summer-150358879.html\" target=\"_blank\">coming to iOS and Android</a> this summer, BlackBerry (BBRY <font color=\"red\">-4.5%</font>) announces at Live (<a href=\"https://seekingalpha.com/currents/post/1023661\" target=\"_blank\">webcast</a>). Had this move been made 2-3 years ago, BlackBerry would've had a shot at dominating a giant mobile IM market. But now, it faces <a href=\"https://seekingalpha.com/currents/post/919381\" target=\"_blank\">intense competition</a> from the likes of WhatsApp, Kik, Viber, and Facebook Messenger, many of whom have 100M+ users. Nonetheless, an installed base of 60M users gives BBM a chance to make some headway. BlackBerry is also launching BBM Channels, a platform for connecting to brands and celebrities, and <a href=\"http://allthingsd.com/20130514/blackberry-messneger-coming-to-iphone-and-android-this-summer/?mod=atdtweet\" target=\"_blank\">Thorsten Heins promises</a> the iOS/Android versions of BBM will eventually support VoIP and screen sharing.</p><div class=\"tiny-share-widget\" data-id=\"1023951\" data-linked=\"BlackBerry Messenger is coming to iOS and Android this summer, BlackBerry (BBRY -4.5%) announces...\" data-tweet=\"$BB - BlackBerry Messenger is coming to iOS and Android this summer, BlackBerry (BBRY -4.5%) announces at Live (webcast). Had this move been made 2-3 years ago, BlackBerry would&#39;ve had a shot at dominating a giant mobile IM market. But now, it faces int... https://seekingalpha.com/news/1023951?source=tweet\" data-url=\"https://seekingalpha.com/news/1023951\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>42&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1023941\" data-ts=\"1368545276\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHFS\" target=\"_blank\">CHFS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1023941\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sunshine Heart (SSH +5.5%) moves up after reporting a Q1 net loss of $4.4M, or $0.47 per share,...</a></h4><p>Sunshine Heart (SSH <font color=\"green\">+5.5%</font>) moves up after reporting a Q1 net loss of $4.4M, or $0.47 per share, compared to a loss of $4.1M or $0.66 per share in Q112, and beating Street estimates for a loss of $0.51. The company ended the quarter with $11M in cash, compared to $14.2 million at the end of FY12. Looking forward, the company says it's currently in discussions with physicians regarding the potential weaning of additional patients from its C-Pulse system study, based upon significant improvements since the time of implant.</p><div class=\"tiny-share-widget\" data-id=\"1023941\" data-linked=\"Sunshine Heart (SSH +5.5%) moves up after reporting a Q1 net loss of $4.4M, or $0.47 per share,...\" data-tweet=\"$CHFS - Sunshine Heart (SSH +5.5%) moves up after reporting a Q1 net loss of $4.4M, or $0.47 per share, compared to a loss of $4.1M or $0.66 per share in Q112, and beating Street estimates for a loss of $0.51. The company ended the quarter with $11M in ... https://seekingalpha.com/news/1023941?source=tweet\" data-url=\"https://seekingalpha.com/news/1023941\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:27 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1023931\" data-ts=\"1368544846\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IOC\" target=\"_blank\">IOC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1023931\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">InterOil (IOC +11.6%) shares surge on comments from the company&#39;s Q1 conference call about the...</a></h4><p>InterOil (<a href=\"https://seekingalpha.com/symbol/IOC\" title=\"InterOil Corporation\">IOC</a> <font color=\"green\">+11.6%</font>) shares surge on comments from the company's <a href=\"http://www.streetinsider.com/Conference+Calls/InterOil+%28IOC%29+Up+9%25+as+Investors+Position+for+Partnership+Deal/8335469.html\" target=\"_blank\">Q1 conference call</a> about the ongoing partnership selection for its Papua New Guinea liquefied natural gas project. The company says it is in the final stages of a selection after receiving several bids, and there is no June 30 deadline. (<a href=\"https://seekingalpha.com/currents/post/1022251\" target=\"_blank\">Q1 earnings</a>)</p><div class=\"tiny-share-widget\" data-id=\"1023931\" data-linked=\"InterOil (IOC +11.6%) shares surge on comments from the company&#39;s Q1 conference call about the...\" data-tweet=\"$IOC - InterOil (IOC +11.6%) shares surge on comments from the company&#39;s Q1 conference call about the ongoing partnership selection for its Papua New Guinea liquefied natural gas project. The company says it is in the final stages of a selection after r... https://seekingalpha.com/news/1023931?source=tweet\" data-url=\"https://seekingalpha.com/news/1023931\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:20 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1023921\" data-ts=\"1368544755\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BVSN\" target=\"_blank\">BVSN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1023921\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Two old Jonathan Lebed/momentum trader favorites - BroadVision (BVSN +14.9%) and Synacor (SYNC...</a></h4><p>Two old Jonathan Lebed/momentum trader favorites - BroadVision (<a href=\"https://seekingalpha.com/symbol/BVSN\" title=\"BroadVision, Inc.\">BVSN</a> <font color=\"green\">+14.9%</font>) and Synacor (<a href=\"https://seekingalpha.com/symbol/SYNC\" title=\"Synacor\">SYNC</a> <font color=\"green\">+16.1%</font>) - are shooting higher. This morning, BroadVision announced giant Japanese carrier NTT will use the company's software to power a cloud-based enterprise task management service, and Synacor announced (in what doesn't seem like big news) it would demo its <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/935821\">Cloud ID</a> solution (allows TV Everywhere logins via Facebook/Twitter/Google+) at this week's Google I/O conference.</p><div class=\"tiny-share-widget\" data-id=\"1023921\" data-linked=\"Two old Jonathan Lebed/momentum trader favorites - BroadVision (BVSN +14.9%) and Synacor (SYNC...\" data-tweet=\"$BVSN $BVSN $SYNC - Two old Jonathan Lebed/momentum trader favorites - BroadVision (BVSN +14.9%) and Synacor (SYNC +16.1%) - are shooting higher. This morning, BroadVision announced giant Japanese carrier NTT will use the company&#39;s software to power a c... https://seekingalpha.com/news/1023921?source=tweet\" data-url=\"https://seekingalpha.com/news/1023921\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1023901\" data-ts=\"1368544168\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PLUG\" target=\"_blank\">PLUG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1023901\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Plug Power (PLUG +5.8%) shrugs off a Q1 EPS miss to trade higher as revenues come in better than...</a></h4><p>Plug Power (<a href=\"https://seekingalpha.com/symbol/PLUG\" title=\"Plug Power, Inc.\">PLUG</a> <font color=\"green\">+5.8%</font>) shrugs off a <a href=\"https://seekingalpha.com/market_currents/post/1023521\" target=\"_blank\">Q1 EPS miss</a> to trade higher as revenues come in better than Street estimates. Total sales declined 18% Y/Y as product and service revenue and research and development contract revenue both declined. Nevertheless, it beat the Street, and in this market, appearances seem to be all that's necessary to drive a stock higher.</p><div class=\"tiny-share-widget\" data-id=\"1023901\" data-linked=\"Plug Power (PLUG +5.8%) shrugs off a Q1 EPS miss to trade higher as revenues come in better than...\" data-tweet=\"$PLUG - Plug Power (PLUG +5.8%) shrugs off a Q1 EPS miss to trade higher as revenues come in better than Street estimates. Total sales declined 18% Y/Y as product and service revenue and research and development contract revenue both declined. Neverthel... https://seekingalpha.com/news/1023901?source=tweet\" data-url=\"https://seekingalpha.com/news/1023901\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:09 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1023851\" data-ts=\"1368543531\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MM\" target=\"_blank\">MM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1023851\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Millennial Media (MM +8.5%) is now up 12% over the last two days. Yesterday, Millennial...</a></h4><p>Millennial Media (<a href=\"https://seekingalpha.com/symbol/MM\" title=\"Millennial Media, Inc.\">MM</a> <font color=\"green\">+8.5%</font>) is now <font color=\"green\">up 12%</font> over the last two days. Yesterday, Millennial announced the launch of a Japanese unit - the Japanese mobile content market hasn't been easy for foreign firms to crack. Millennial's gains come as mobile ad peer Velti (<a href=\"https://seekingalpha.com/symbol/VELT\" title=\"\">VELT</a> <font color=\"red\">-9.5%</font>) dives after announcing another <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/1022371\">revenue miss</a> and <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/1022511\">bleak guidance</a> (as well as a COO change). On its <a target=\"_blank\" href=\"https://seekingalpha.com/article/1431841-velti-plc-management-discusses-q1-2013-results-earnings-call-transcript\">earnings call</a>, Velti stated <a target=\"_blank\" href=\"http://www.investopedia.com/terms/d/dso.asp\">days sales outstanding</a> was still a whopping 309 days at the end of Q1, but promised full-year DSO would be under 100 days. The cash-strapped company expects free cash flow to be around -$8M to -$12M in Q2, before \"a significant amount of cash flow\" is produced in Q3.</p><div class=\"tiny-share-widget\" data-id=\"1023851\" data-linked=\"Millennial Media (MM +8.5%) is now up 12% over the last two days. Yesterday, Millennial...\" data-tweet=\"$MM $MM $VELTF - Millennial Media (MM +8.5%) is now up 12% over the last two days. Yesterday, Millennial announced the launch of a Japanese unit - the Japanese mobile content market hasn&#39;t been easy for foreign firms to crack. Millennial&#39;s gains come as... https://seekingalpha.com/news/1023851?source=tweet\" data-url=\"https://seekingalpha.com/news/1023851\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1023791\" data-ts=\"1368542280\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SSYS\" target=\"_blank\">SSYS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1023791\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">3D printing stocks are ripping higher a day after Stratasys (NASDAQ:SSYS) delivered a Q1 EPS...</a></h4><p>3D printing stocks are ripping higher a day after Stratasys (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SSYS\" title=\"Stratasys, Inc.\">SSYS</a>) delivered a <a href=\"https://seekingalpha.com/currents/post/1020911\" target=\"_blank\">Q1 EPS beat</a>, and hours before ExOne (NASDAQ:<a href=\"https://seekingalpha.com/symbol/XONE\" title=\"ExOne\">XONE</a>) posts its own Q1 report. <a href=\"https://seekingalpha.com/symbol/DDD\" title=\"3D Systems Corp.\">DDD</a> <font color=\"green\">+8.4%</font>. <a href=\"https://seekingalpha.com/symbol/SSYS\" title=\"Stratasys, Inc.\">SSYS</a> <font color=\"green\">+7.9%</font>. <a href=\"https://seekingalpha.com/symbol/XONE\" title=\"ExOne\">XONE</a> <font color=\"green\">+6.9%</font>. <a href=\"https://seekingalpha.com/symbol/CIMT\" title=\"Cimatron, Limited\">CIMT</a> <font color=\"green\">+4.1%</font>. <a href=\"http://www.streetinsider.com/Analyst+Comments/Canaccord+Genuity+Lifts+PT+on+Stratasys+%28SSYS%29+to+%2495/8334669.html\" target=\"_blank\">Canaccord</a> and <a href=\"http://www.streetinsider.com/Analyst+Comments/Needham+%26+Company+Lifts+Price+Target+on+Stratasy+%28SSYS%29%3B+Sees+10%25+Upside/8334415.html\" target=\"_blank\">Needham</a> have raised their PTs for Stratasys today: Canaccord considers 2013 guidance conservative in light of management's <a href=\"https://seekingalpha.com/currents/post/1021571\" target=\"_blank\">gross margin comments</a>, and Needham foresees improved operating leverage as <a href=\"https://seekingalpha.com/currents/post/251451\" target=\"_blank\">Objet merger</a> integration continues.</p><div class=\"tiny-share-widget\" data-id=\"1023791\" data-linked=\"3D printing stocks are ripping higher a day after Stratasys (NASDAQ:SSYS) delivered a Q1 EPS...\" data-tweet=\"$SSYS $SSYS $XONE - 3D printing stocks are ripping higher a day after Stratasys (NASDAQ:SSYS) delivered a Q1 EPS beat, and hours before ExOne (NASDAQ:XONE) posts its own Q1 report. DDD +8.4%. SSYS +7.9%. XONE +6.9%. CIMT +4.1%. Canaccord and Needham hav... https://seekingalpha.com/news/1023791?source=tweet\" data-url=\"https://seekingalpha.com/news/1023791\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:38 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1023751\" data-ts=\"1368541437\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEAR\" target=\"_blank\">TEAR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1023751\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TearLab (TEAR +10.6%) ramps higher this morning after reporting Q1 sales that topped the...</a></h4><p>TearLab (<a href=\"https://seekingalpha.com/symbol/TEAR\" title=\"TearLab Corporation\">TEAR</a> <font color=\"green\">+10.6%</font>) ramps higher this morning after reporting <a href=\"https://seekingalpha.com/market_currents/post/1022221\" target=\"_blank\">Q1 sales</a> that topped the Street's $2.19M estimate. Net revenues soared 486% from the same period last year, and an increase of 54% sequentially from the previous quarter. A total of 388 orders for its TearLab Osmolarity systems were booked in Q1. Net losses for the quarter were $9.1M, including approximately $6.6M in non-cash expense related to the revaluation of warrants issued in June 2011. As of March 31, the company had $12.3M remaining in cash.</p><div class=\"tiny-share-widget\" data-id=\"1023751\" data-linked=\"TearLab (TEAR +10.6%) ramps higher this morning after reporting Q1 sales that topped the...\" data-tweet=\"$TEAR - TearLab (TEAR +10.6%) ramps higher this morning after reporting Q1 sales that topped the Street&#39;s $2.19M estimate. Net revenues soared 486% from the same period last year, and an increase of 54% sequentially from the previous quarter. A total of... https://seekingalpha.com/news/1023751?source=tweet\" data-url=\"https://seekingalpha.com/news/1023751\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:23 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1023741\" data-ts=\"1368541412\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INSM\" target=\"_blank\">INSM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1023741\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Insmed (INSM +3.6%) pop after the company says the European Patent Office will grant a...</a></h4><p>Shares of Insmed (<a href=\"https://seekingalpha.com/symbol/INSM\" title=\"Insmed, Inc.\">INSM</a> <font color=\"green\">+3.6%</font>) pop after the company says the European Patent Office will grant a patent on ARIKACE, the company's clinical stage, inhaled treatment for cystic fibrosis patients with lung infections. In an exhaustive rundown, SA contributor Scott Matusow claims the drug is a superior alternative to Novartis' (NYSE:<a href=\"https://seekingalpha.com/symbol/NVS\" title=\"Novartis AG\">NVS</a>) TOBI for a number of reasons and also says INSM <a href=\"https://seekingalpha.com/article/1431661-significant-near-term-top-line-data-catalyst-and-platform-technology-should-propel-insmed\" target=\"_blank\">could capture a significant portion</a> of the $424M (annually) market for CF pseudomonas lung infection treatments if top-line Phase III results (due mid-year) show promise.</p><div class=\"tiny-share-widget\" data-id=\"1023741\" data-linked=\"Shares of Insmed (INSM +3.6%) pop after the company says the European Patent Office will grant a...\" data-tweet=\"$INSM $INSM $NVS - Shares of Insmed (INSM +3.6%) pop after the company says the European Patent Office will grant a patent on ARIKACE, the company&#39;s clinical stage, inhaled treatment for cystic fibrosis patients with lung infections. In an exhaustive ru... https://seekingalpha.com/news/1023741?source=tweet\" data-url=\"https://seekingalpha.com/news/1023741\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:23 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1023721\" data-ts=\"1368540807\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVG\" target=\"_blank\">AVG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1023721\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Goldman cuts AVG (AVG -2.7%) to Neutral on valuation grounds, stating it sees &quot;more attractive...</a></h4>Goldman cuts AVG (<a href='https://seekingalpha.com/symbol/AVG' title='AVG Technologies'>AVG</a> <font color='red'>-2.7%</font>) to Neutral on valuation grounds, stating it sees \"more attractive upside in other names\" following <a href=\"https://www.google.com/finance?chdnp=1&amp;chdd=1&amp;chds=1&amp;chdv=1&amp;chvs=maximized&amp;chdeh=0&amp;chfdeh=0&amp;chdet=1368561600000&amp;chddm=7116&amp;chls=IntervalBasedLine&amp;q=NYSE:AVG&amp;ntsp=0&amp;ei=jUSSUciCIYb_igLZFg\" target=\"_blank\">recent gains</a>. Though shares only trade at 7x estimated 2013 <a href=\"http://www.stockopedia.co.uk/ratios/ev-free-cash-flow-336/\" target=\"_blank\">EV/unlevered FCF</a>, Goldman argues the valuation is justified given the risk related to Platform (search toolbar) revenue amidst a <a href=\"https://seekingalpha.com/currents/post/719781\" target=\"_blank\">transition from Google to Yahoo</a>, and <a href=\"https://seekingalpha.com/currents/post/876251\" target=\"_blank\">CEO transition</a> uncertainty. But it still thinks AVG will keep gaining share in the antivirus software market via its freemium model, and also sees growth for its <a href=\"http://www.avg.com/us-en/internet-security\" target=\"_blank\">Subscription Security</a> and <a href=\"http://www.avg.com/us-en/avg-pctuneup\" target=\"_blank\">Tune Up</a> ops.<div class=\"tiny-share-widget\" data-id=\"1023721\" data-linked=\"Goldman cuts AVG (AVG -2.7%) to Neutral on valuation grounds, stating it sees &quot;more attractive...\" data-tweet=\"$AVG - Goldman cuts AVG (AVG -2.7%) to Neutral on valuation grounds, stating it sees &quot;more attractive upside in other names&quot; following recent gains. Though shares only trade at 7x estimated 2013 EV/unlevered FCF, Goldman argues the valuation is justifie... https://seekingalpha.com/news/1023721?source=tweet\" data-url=\"https://seekingalpha.com/news/1023721\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:13 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1023711\" data-ts=\"1368540772\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AIG\" target=\"_blank\">AIG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1023711\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Up 2.1%, AIG is back near its 52-week high as David Tepper gives the stock a shout on his CNBC...</a></h4><font color=\"green\">Up 2.1%</font>, <a href=\"https://seekingalpha.com/symbol/AIG\" title=\"American International Group Inc\">AIG</a> is back near its 52-week high as David Tepper gives the stock a shout on his <a href=\"https://seekingalpha.com/currents/post/1023101\" target=\"_blank\">CNBC interview</a> and Jeremy Hoskins - presenting at London Value - makes the <a href=\"http://www.marketfolly.com/2013/05/jeremy-hoskings-presentation-at-london.html\" target=\"_blank\">familiar bull case</a>: Trading at a fraction of book value, a cyclical improvement in underwriting results, and a hoped-for $5B/year in buybacks reducing the share count by 30% by 2015. The <a href=\"http://finance.yahoo.com/q?s=AIG-WT%2C+&amp;ql=0\" target=\"_blank\">TARP warrants</a> <font color=\"green\">+2.2%</font> to $19.31.<div class=\"tiny-share-widget\" data-id=\"1023711\" data-linked=\"Up 2.1%, AIG is back near its 52-week high as David Tepper gives the stock a shout on his CNBC...\" data-tweet=\"$AIG - Up 2.1%, AIG is back near its 52-week high as David Tepper gives the stock a shout on his CNBC interview and Jeremy Hoskins - presenting at London Value - makes the familiar bull case: Trading at a fraction of book value, a cyclical improvement i... https://seekingalpha.com/news/1023711?source=tweet\" data-url=\"https://seekingalpha.com/news/1023711\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1023681\" data-ts=\"1368540129\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANTM\" target=\"_blank\">ANTM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1023681\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">&quot;We believe one of the biggest questions on investors&#39; minds is can [they] grow FY14 earnings,&quot;...</a></h4><p>\"We believe one of the biggest questions on investors' minds is can [they] grow FY14 earnings,\" says Jefferies, stating what might fairly be called \"the obvious\" in a note <a href=\"http://www.dividend.com/news/2013/jefferies-upgrades-wellpoint-to-buy-on-expected-earnings-growth-wlp/\" target=\"_blank\">upgrading</a> WellPoint (WLP <font color=\"green\">+1.5%</font>) to Buy from Hold and raising the stock's price target to $92. After a \"deep dive\" analysis, the investment bank says it sees 7-8% EPS growth against the Street's 2.4% consensus and predicts $8.61 per share for FY14, making WLP the cheapest MCO stock, trading at 8.8x forward earnings. Meanwhile, Cigna (<a href=\"https://seekingalpha.com/symbol/CI\" title=\"Cigna Corporation\">CI</a> <font color=\"red\">-1.8%</font>) is \"ready for a breather\" and catches a downgrade to Hold from Buy \u2014 CI's CFO Ralph Nicoletti announced Monday he is leaving the company for personal reasons.</p><div class=\"tiny-share-widget\" data-id=\"1023681\" data-linked=\"&quot;We believe one of the biggest questions on investors&#39; minds is can [they] grow FY14 earnings,&quot;...\" data-tweet=\"$ANTM $ANTM $CI - &quot;We believe one of the biggest questions on investors&#39; minds is can [they] grow FY14 earnings,&quot; says Jefferies, stating what might fairly be called &quot;the obvious&quot; in a note upgrading WellPoint (WLP +1.5%) to Buy from Hold and raising th... https://seekingalpha.com/news/1023681?source=tweet\" data-url=\"https://seekingalpha.com/news/1023681\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:02 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1023641\" data-ts=\"1368539447\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SODA\" target=\"_blank\">SODA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1023641\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SodaStream (SODA +8.6%) trades higher as momentum continues to build for the beverage system...</a></h4><p>SodaStream (<a href=\"https://seekingalpha.com/symbol/SODA\" title=\"SodaStream International\">SODA</a> <font color=\"green\">+8.6%</font>) trades higher as momentum continues to build for the beverage system company following its quarterly earnings report. Today's sentiment could be getting a nice lift from Citibank analysts who think sales <a target=\"_blank\" href=\"https://twitter.com/markflowchatter/status/334099617824256000\">could exceed</a> $1B this year after taking in SodaStream's <a target=\"_blank\" href=\"http://sodastream.investorroom.com/index.php?s=19\">Investor and Analyst Day presentation</a>.</p><div class=\"tiny-share-widget\" data-id=\"1023641\" data-linked=\"SodaStream (SODA +8.6%) trades higher as momentum continues to build for the beverage system...\" data-tweet=\"$SODA - SodaStream (SODA +8.6%) trades higher as momentum continues to build for the beverage system company following its quarterly earnings report. Today&#39;s sentiment could be getting a nice lift from Citibank analysts who think sales could exceed $1B ... https://seekingalpha.com/news/1023641?source=tweet\" data-url=\"https://seekingalpha.com/news/1023641\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1023611\" data-ts=\"1368538978\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INO\" target=\"_blank\">INO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1023611\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Inovio Pharmaceuticals (INO +6.6%) pops after saying its SynCon DNA vaccine for the Marburg and...</a></h4><p>Inovio Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/INO\" title=\"Inovio Pharmaceuticals, Inc.\">INO</a> <font color=\"green\">+6.6%</font>) pops after saying its SynCon DNA vaccine for the Marburg and Ebola viruses provides 100% protection against death. (PR)</p><div class=\"tiny-share-widget\" data-id=\"1023611\" data-linked=\"Inovio Pharmaceuticals (INO +6.6%) pops after saying its SynCon DNA vaccine for the Marburg and...\" data-tweet=\"$INO - Inovio Pharmaceuticals (INO +6.6%) pops after saying its SynCon DNA vaccine for the Marburg and Ebola viruses provides 100% protection against death. (PR) https://seekingalpha.com/news/1023611?source=tweet\" data-url=\"https://seekingalpha.com/news/1023611\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1023581\" data-ts=\"1368538384\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EW\" target=\"_blank\">EW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1023581\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Edwards Lifesciences (EW +2.7%) news roundup: Company authorizes a new $750M buyback program and...</a></h4><p>Edwards Lifesciences (<a href=\"https://seekingalpha.com/symbol/EW\" title=\"Edwards Lifesciences Corp\">EW</a> <font color=\"green\">+2.7%</font>) news roundup: Company authorizes a new $750M buyback program and says it will complete the remainder ($140M) of its previously authorized repurchase program during Q2; CEO Michael Mussallem will purchase $5M worth of shares tomorrow at either Wednesday's closing price or the average closing price for the 10 trading days ending Monday, whichever is higher; CFO Thomas Abate will retire this year. Despite a 5-day, ~5% rally, the shares are still reeling from April 24th's <a href=\"https://seekingalpha.com/currents/post/963121\" target=\"_blank\">post-earnings dive</a> and subsequent downgrades.</p><div class=\"tiny-share-widget\" data-id=\"1023581\" data-linked=\"Edwards Lifesciences (EW +2.7%) news roundup: Company authorizes a new $750M buyback program and...\" data-tweet=\"$EW - Edwards Lifesciences (EW +2.7%) news roundup: Company authorizes a new $750M buyback program and says it will complete the remainder ($140M) of its previously authorized repurchase program during Q2; CEO Michael Mussallem will purchase $5M worth o... https://seekingalpha.com/news/1023581?source=tweet\" data-url=\"https://seekingalpha.com/news/1023581\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:33 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1023561\" data-ts=\"1368538176\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARE\" target=\"_blank\">ARE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1023561\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alexandria Real Estate Equities (NYSE:ARE) takes advantage of a big post-earnings run, executing...</a></h4><p>Alexandria Real Estate Equities (NYSE:<a href=\"https://seekingalpha.com/symbol/ARE\" title=\"Alexandria Real Estate Equities Inc.\">ARE</a>) takes advantage of a big post-earnings run, executing an upsized secondary offering of 6.6M shares at $73.50 each (was 6M previously). The company will initially pay down its credit line in order to redraw as it sees acquisition opportunities. Shares <font color=\"red\">-1.8%</font> premarket to $74.30. (PR)</p><div class=\"tiny-share-widget\" data-id=\"1023561\" data-linked=\"Alexandria Real Estate Equities (NYSE:ARE) takes advantage of a big post-earnings run, executing...\" data-tweet=\"$ARE - Alexandria Real Estate Equities (NYSE:ARE) takes advantage of a big post-earnings run, executing an upsized secondary offering of 6.6M shares at $73.50 each (was 6M previously). The company will initially pay down its credit line in order to redr... https://seekingalpha.com/news/1023561?source=tweet\" data-url=\"https://seekingalpha.com/news/1023561\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:29 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1023541\" data-ts=\"1368538061\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NOK\" target=\"_blank\">NOK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1023541\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">The Lumia 925 (NYSE:NOK) is officially revealed. Thanks to its aluminum frame, it&#39;s ~50g lighter...</a></h4><p>The Lumia 925 (NYSE:<a href=\"https://seekingalpha.com/symbol/NOK\" title=\"Nokia Corporation\">NOK</a>) is <a target=\"_blank\" href=\"http://www.engadget.com/2013/05/14/nokia-announces-the-lumia-925-a-thinner-lighter-aluminum-body/\">officially revealed</a>. Thanks to its aluminum frame, it's ~50g lighter than the 920, and ~30g lighter than the 928. Otherwise, the specs resemble <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/1018551\">the 928's</a>: a 4.5,\" 1280x768, OLED display, a dual-core, 1.5 GHz., Qualcomm (NASDAQ:<a href=\"https://seekingalpha.com/symbol/QCOM\" title=\"Qualcomm Inc.\">QCOM</a>) processor, and an 8.7MP camera with optical image stabilization. There's no xenon flash, but there is an advanced camera app that leverages <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/367801\">Scalado</a>. Nokia will be charging a steep unsubsidized price of \u20ac469 ($609) when the 925 hits China and Europe this June. But T-Mobile USA (NASDAQ:<a href=\"https://seekingalpha.com/symbol/TMUS\" title=\"T-Mobile US, Inc.\">TMUS</a>) is <a target=\"_blank\" href=\"http://allthingsd.com/20130514/nokia-debuts-aluminum-clad-lumia-925-headed-to-t-mobile-usa-and-vodaone/\">expected to sell it</a> for less than $100 subsidized. Shares <font color=\"red\">-5%</font>. Were investors expecting a <a target=\"_blank\" href=\"https://seekingalpha.com/currents/post/808121\">41MP sensor PureView phone</a>?</p><div class=\"tiny-share-widget\" data-id=\"1023541\" data-linked=\"The Lumia 925 (NYSE:NOK) is officially revealed. Thanks to its aluminum frame, it&#39;s ~50g lighter...\" data-tweet=\"$NOK $NOK $QCOM - The Lumia 925 (NYSE:NOK) is officially revealed. Thanks to its aluminum frame, it&#39;s ~50g lighter than the 920, and ~30g lighter than the 928. Otherwise, the specs resemble the 928&#39;s: a 4.5,&quot; 1280x768, OLED display, a dual-core, 1.5 GHz... https://seekingalpha.com/news/1023541?source=tweet\" data-url=\"https://seekingalpha.com/news/1023541\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>26&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1023491\" data-ts=\"1368537523\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MOSY\" target=\"_blank\">MOSY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1023491\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MoSys (NASDAQ:MOSY) falls 12.58% premarket after pricing a 6.5M share public offering at $4,...</a></h4><p>MoSys (NASDAQ:<a href=\"https://seekingalpha.com/symbol/MOSY\" title=\"MoSys, Inc.\">MOSY</a>) falls <font color=\"red\">12.58%</font> premarket after pricing a 6.5M share public offering at $4, 17.25% below Monday's close. The deal's underwriters have an option for an additional 975K shares to cover overallotments. (PR)</p><div class=\"tiny-share-widget\" data-id=\"1023491\" data-linked=\"MoSys (NASDAQ:MOSY) falls 12.58% premarket after pricing a 6.5M share public offering at $4,...\" data-tweet=\"$MOSY - MoSys (NASDAQ:MOSY) falls 12.58% premarket after pricing a 6.5M share public offering at $4, 17.25% below Monday&#39;s close. The deal&#39;s underwriters have an option for an additional 975K shares to cover overallotments. (PR) https://seekingalpha.com/news/1023491?source=tweet\" data-url=\"https://seekingalpha.com/news/1023491\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1023451\" data-ts=\"1368537202\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FIO\" target=\"_blank\">FIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1023451\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fusion-io (NYSE:FIO) +4.8% on an upgrade to Buy from UBS&#39; Steve Milunovich. Though concerned...</a></h4>Fusion-io (NYSE:<a href='https://seekingalpha.com/symbol/FIO' title='Fusion-io, Inc.'>FIO</a>) <font color=\"green\">+4.8%</font> on an <a href=\"http://www.streetinsider.com/Hot+Upgrades/UPDATE%3A+UBS+Upgrades+Fusion-io+%28FIO%29+to+Buy/8333966.html\" target=\"_blank\">upgrade to Buy</a> from UBS' Steve Milunovich. Though concerned about the sustainability of Fusion-io's competitive edge, Milunovich thinks the recent selloff \"overcompensates for near-term risks,\" particularly in light of a <a href=\"https://seekingalpha.com/currents/post/965261\" target=\"_blank\">solid FQ3 report</a>. Shares are still <font color=\"red\">down 16%</font> since Fusion-io announced CEO David Flynn and CMO Rick White are <a href=\"https://seekingalpha.com/currents/post/1009001\" target=\"_blank\">leaving</a>.<div class=\"tiny-share-widget\" data-id=\"1023451\" data-linked=\"Fusion-io (NYSE:FIO) +4.8% on an upgrade to Buy from UBS&#39; Steve Milunovich. Though concerned...\" data-tweet=\"$FIO - Fusion-io (NYSE:FIO) +4.8% on an upgrade to Buy from UBS&#39; Steve Milunovich. Though concerned about the sustainability of Fusion-io&#39;s competitive edge, Milunovich thinks the recent selloff &quot;overcompensates for near-term risks,&quot; particularly in lig... https://seekingalpha.com/news/1023451?source=tweet\" data-url=\"https://seekingalpha.com/news/1023451\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:13 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1023441\" data-ts=\"1368537050\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IDXG\" target=\"_blank\">IDXG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1023441\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket gainers: PDII +33%. ECTY +20%. NSPH +18%. SNE +9%. WPX +8%. TTWO +6%. TSLA +6%. RENN...</a></h4><b>Premarket gainers:</b> PDII <font color=\"green\">+33%</font>. ECTY <font color=\"green\">+20%</font>. <a href=\"https://seekingalpha.com/symbol/NSPH\" title=\"Nanosphere, Inc.\">NSPH</a> <font color=\"green\">+18%</font>. <a href=\"https://seekingalpha.com/symbol/SNE\" title=\"Sony Corporation\">SNE</a> <font color=\"green\">+9%</font>. <a href=\"https://seekingalpha.com/symbol/WPX\" title=\"WPX Energy, Inc.\">WPX</a> <font color=\"green\">+8%</font>. <a href=\"https://seekingalpha.com/symbol/TTWO\" title=\"Take-Two Interactive Software, Inc.\">TTWO</a> <font color=\"green\">+6%</font>. <a href=\"https://seekingalpha.com/symbol/TSLA\" title=\"Tesla, Inc.\">TSLA</a> <font color=\"green\">+6%</font>. <a href=\"https://seekingalpha.com/symbol/RENN\" title=\"Renren Inc.\">RENN</a> <font color=\"green\">+5%</font>.<br> <b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/TRMD-OLD\" title=\"Steamship Co. Torm A/S\">TRMD-OLD</a> <font color=\"red\">-15%</font>. <a href=\"https://seekingalpha.com/symbol/MOSY\" title=\"MoSys, Inc.\">MOSY</a> <font color=\"red\">-13%</font>. <a href=\"https://seekingalpha.com/symbol/PT-OLD\" title=\"Portugal Telecom SGPS SA\">PT-OLD</a> <font color=\"red\">-11%</font>. <a href=\"https://seekingalpha.com/symbol/VELT\" title=\"\">VELT</a> <font color=\"red\">-10%</font>. SCTY <font color=\"red\">-10%</font>. <a href=\"https://seekingalpha.com/symbol/TSL\" title=\"Trina Solar Limited\">TSL</a> <font color=\"red\">-6%</font>. NBG <font color=\"red\">-6%</font>.<div class=\"tiny-share-widget\" data-id=\"1023441\" data-linked=\"Premarket gainers: PDII +33%. ECTY +20%. NSPH +18%. SNE +9%. WPX +8%. TTWO +6%. TSLA +6%. RENN...\" data-tweet=\"$IDXG $IDXG $ECTYQ - Premarket gainers: PDII +33%. ECTY +20%. NSPH +18%. SNE +9%. WPX +8%. TTWO +6%. TSLA +6%. RENN +5%. Losers: TRMD-OLD -15%. MOSY -13%. PT-OLD -11%. VELT -10%. SCTY -10%. TSL -6%. NBG -6%. https://seekingalpha.com/news/1023441?source=tweet\" data-url=\"https://seekingalpha.com/news/1023441\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:10 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1023411\" data-ts=\"1368536532\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVDA\" target=\"_blank\">NVDA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1023411\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nvidia (NASDAQ:NVDA) strikes a deal with Goldman allowing the chipmaker to buyback $750M worth...</a></h4><p>Nvidia (NASDAQ:<a href=\"https://seekingalpha.com/symbol/NVDA\" title=\"NVIDIA Corporation\">NVDA</a>) strikes a deal with Goldman allowing the chipmaker to <a href=\"http://www.marketwatch.com/story/nvidia-in-goldman-deal-to-buy-back-750m-shares-2013-05-14\" target=\"_blank\">buyback $750M worth of shares</a>. The company previously said it would return $1B to stockholders this year. Shares <font color=\"green\">+1.76%</font> premarket.</p><div class=\"tiny-share-widget\" data-id=\"1023411\" data-linked=\"Nvidia (NASDAQ:NVDA) strikes a deal with Goldman allowing the chipmaker to buyback $750M worth...\" data-tweet=\"$NVDA - Nvidia (NASDAQ:NVDA) strikes a deal with Goldman allowing the chipmaker to buyback $750M worth of shares. The company previously said it would return $1B to stockholders this year. Shares +1.76% premarket. https://seekingalpha.com/news/1023411?source=tweet\" data-url=\"https://seekingalpha.com/news/1023411\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:02 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1023371\" data-ts=\"1368536048\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EAC\" target=\"_blank\">EAC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1023371\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Erickson Air-Crane (NASDAQ:EAC) looks set to extend a two-day-old rally as shares rise 2.39%...</a></h4><p>Erickson Air-Crane (NASDAQ:<a href=\"https://seekingalpha.com/symbol/EAC\" title=\"Erickson Air-Crane\">EAC</a>) looks set to extend a two-day-old rally as shares <font color=\"green\">rise 2.39%</font> premarket. The stock is <font color=\"green\">up 25%</font> since Thursday, when the company reported adjusted Q1 earnings that beat estimates and said revenue hit a record $36.9M for the quarter. EAC also updated its guidance. SA contributor Super-trades thinks the shares <a target=\"_blank\" href=\"https://seekingalpha.com/article/1429151-erickson-air-crane-updates-guidance-why-shares-should-be-valued-at-40-60\">are worth $56.57</a> based on the average EBITDA multiple of what he says is the stock's peer group. (<a target=\"_blank\" href=\"https://seekingalpha.com/article/1422341-erickson-air-crane-s-ceo-discusses-q1-2013-results-earnings-call-transcript\">CC transcript</a>)</p><div class=\"tiny-share-widget\" data-id=\"1023371\" data-linked=\"Erickson Air-Crane (NASDAQ:EAC) looks set to extend a two-day-old rally as shares rise 2.39%...\" data-tweet=\"$EAC - Erickson Air-Crane (NASDAQ:EAC) looks set to extend a two-day-old rally as shares rise 2.39% premarket. The stock is up 25% since Thursday, when the company reported adjusted Q1 earnings that beat estimates and said revenue hit a record $36.9M fo... https://seekingalpha.com/news/1023371?source=tweet\" data-url=\"https://seekingalpha.com/news/1023371\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:54 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1023321\" data-ts=\"1368535558\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BKS\" target=\"_blank\">BKS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1023321\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Barnes &amp;amp; Noble (NYSE:BKS) falls 4.6% premarket as traders try to sort out what kind of...</a></h4><p>Barnes &amp; Noble (NYSE:<a href=\"https://seekingalpha.com/symbol/BKS\" title=\"Barnes &amp; Noble Inc\">BKS</a>) <font color=\"red\">falls 4.6%</font> premarket as traders try to sort out what kind of premium to place on shares for the potential of an <a href=\"https://seekingalpha.com/currents/post/1014061\" target=\"_blank\">eventual buyout</a> by Microsoft of Nook Media. With <a href=\"https://seekingalpha.com/currents/post/1021661\" target=\"_blank\">dueling sources</a> saying different things on the likelihood of a deal, BKS trades near the mid-point of its post-rumor rally.</p><div class=\"tiny-share-widget\" data-id=\"1023321\" data-linked=\"Barnes &amp;amp; Noble (NYSE:BKS) falls 4.6% premarket as traders try to sort out what kind of...\" data-tweet=\"$BKS - Barnes &amp; Noble (NYSE:BKS) falls 4.6% premarket as traders try to sort out what kind of premium to place on shares for the potential of an eventual buyout by Microsoft of Nook Media. With dueling sources saying different things on the likelihood o... https://seekingalpha.com/news/1023321?source=tweet\" data-url=\"https://seekingalpha.com/news/1023321\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:45 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1023311\" data-ts=\"1368535127\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NLSN\" target=\"_blank\">NLSN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1023311\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nielsen (NYSE:NLSN) prices its 35M share secondary offering at $35.01 per share. NLSN -0.5%...</a></h4><p>Nielsen (NYSE:<a href=\"https://seekingalpha.com/symbol/NLSN\" title=\"Nielsen Holdings N.V.\">NLSN</a>) prices its 35M share secondary offering at $35.01 per share. NLSN <font color=\"red\">-0.5%</font> premarket to $34.85.</p><div class=\"tiny-share-widget\" data-id=\"1023311\" data-linked=\"Nielsen (NYSE:NLSN) prices its 35M share secondary offering at $35.01 per share. NLSN -0.5%...\" data-tweet=\"$NLSN - Nielsen (NYSE:NLSN) prices its 35M share secondary offering at $35.01 per share. NLSN -0.5% premarket to $34.85. https://seekingalpha.com/news/1023311?source=tweet\" data-url=\"https://seekingalpha.com/news/1023311\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:38 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1023261\" data-ts=\"1368534913\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WY\" target=\"_blank\">WY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1023261\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weyerhaeuser (NYSE:WY) moves 1.72% higher premarket after Raymond James upgrades the shares to...</a></h4><p>Weyerhaeuser (NYSE:<a href=\"https://seekingalpha.com/symbol/WY\" title=\"Weyerhaeuser Co.\">WY</a>) moves <font color=\"green\">1.72% higher</font> premarket after Raymond James <a href=\"http://www.streetinsider.com/Analyst+PT+Change/Raymond+James+Upgrades+Weyerhaeuser+%28WY%29+to+Strong+Buy/8334163.html\" target=\"_blank\">upgrades the shares to Strong Buy</a> from Outperform (price target $36).</p><div class=\"tiny-share-widget\" data-id=\"1023261\" data-linked=\"Weyerhaeuser (NYSE:WY) moves 1.72% higher premarket after Raymond James upgrades the shares to...\" data-tweet=\"$WY - Weyerhaeuser (NYSE:WY) moves 1.72% higher premarket after Raymond James upgrades the shares to Strong Buy from Outperform (price target $36). https://seekingalpha.com/news/1023261?source=tweet\" data-url=\"https://seekingalpha.com/news/1023261\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:35 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1023231\" data-ts=\"1368534197\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSL\" target=\"_blank\">TSL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1023231\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trina Solar (NYSE:TSL) -6.2% premarket after cutting its Q1 shipment guidance, estimating solar...</a></h4><p>Trina Solar (NYSE:<a href=\"https://seekingalpha.com/symbol/TSL\" title=\"Trina Solar Limited\">TSL</a>) <font color=\"red\">-6.2%</font> premarket after cutting its Q1 shipment guidance, estimating solar module shipments of 390-400 MW vs. prior guidance of 420-430 MW. TSL also expects Q1 bottom line results will be impacted by an accounts receivables provision reversal of $10.5M-$11.5M and a foreign currency exchange loss of $18.5M-$19.5M.</p><div class=\"tiny-share-widget\" data-id=\"1023231\" data-linked=\"Trina Solar (NYSE:TSL) -6.2% premarket after cutting its Q1 shipment guidance, estimating solar...\" data-tweet=\"$TSL - Trina Solar (NYSE:TSL) -6.2% premarket after cutting its Q1 shipment guidance, estimating solar module shipments of 390-400 MW vs. prior guidance of 420-430 MW. TSL also expects Q1 bottom line results will be impacted by an accounts receivables p... https://seekingalpha.com/news/1023231?source=tweet\" data-url=\"https://seekingalpha.com/news/1023231\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:23 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1023131\" data-ts=\"1368532711\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RIO\" target=\"_blank\">RIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1023131\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rio Tinto (NYSE:RIO) is committed to cutting capex and operating costs and selling non-core...</a></h4><p>Rio Tinto (NYSE:<a href=\"https://seekingalpha.com/symbol/RIO\" title=\"Rio Tinto plc\">RIO</a>) is <a target=\"_blank\" href=\"http://online.wsj.com/article/BT-CO-20130514-704874.html\">committed to cutting</a> capex and operating costs and selling non-core assets while ramping up production, CEO Sam Walsh says. Rio previously announced plans to cut its operating cost base by $3B by the end of 2014 and is on track to cut $2B this year alone, Walsh says, and is targeting a $750M reduction in exploration and evaluation costs this year. RIO <font color=\"red\">-3%</font> premarket.</p><div class=\"tiny-share-widget\" data-id=\"1023131\" data-linked=\"Rio Tinto (NYSE:RIO) is committed to cutting capex and operating costs and selling non-core...\" data-tweet=\"$RIO - Rio Tinto (NYSE:RIO) is committed to cutting capex and operating costs and selling non-core assets while ramping up production, CEO Sam Walsh says. Rio previously announced plans to cut its operating cost base by $3B by the end of 2014 and is on ... https://seekingalpha.com/news/1023131?source=tweet\" data-url=\"https://seekingalpha.com/news/1023131\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1023081\" data-ts=\"1368531882\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNE\" target=\"_blank\">SNE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1023081\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares of Sony (NYSE:SNE) move up 4.4% premarket after Third Point pushes the company to...</a></h4><p>Shares of Sony (NYSE:<a href=\"https://seekingalpha.com/symbol/SNE\" title=\"Sony Corporation\">SNE</a>) move <font color=\"green\">up 4.4%</font> premarket after Third Point <a href=\"https://seekingalpha.com/currents/post/1022771\" target=\"_blank\">pushes</a> the company to consider a breakup to extract value. (<a href=\"http://www.scribd.com/doc/141379751/Dan-Loeb-letter-to-Sony\" target=\"_blank\">Third Point letter to Sony</a>)</p><div class=\"tiny-share-widget\" data-id=\"1023081\" data-linked=\"Shares of Sony (NYSE:SNE) move up 4.4% premarket after Third Point pushes the company to...\" data-tweet=\"$SNE - Shares of Sony (NYSE:SNE) move up 4.4% premarket after Third Point pushes the company to consider a breakup to extract value. (Third Point letter to Sony) https://seekingalpha.com/news/1023081?source=tweet\" data-url=\"https://seekingalpha.com/news/1023081\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:44 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1023041\" data-ts=\"1368531325\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1023041\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tesla Motors (NASDAQ:TSLA) gains 6.2% in premarket trading to reach $93.10 as its dizzying...</a></h4><p>Tesla Motors (NASDAQ:<a href=\"https://seekingalpha.com/symbol/TSLA\" title=\"Tesla, Inc.\">TSLA</a>) <font color=\"green\">gains 6.2%</font> in premarket trading to reach $93.10 as its dizzying post-earnings victory lap continues. Morgan Stanley is out with what is largely a <a target=\"_blank\" href=\"http://www.streetinsider.com/Hot+Comments/A+Short+Sellers+Nightmare...Tesla+%28TSLA%29+is+the+New+Porsche-VW+-+Analyst/8332355.html\">cautionary note</a> before crunching the numbers for the \"extreme\" bull case. The firm says if Tesla achieves a 20% operating margin on 200K units per year, then a $300-plus price target could be justified.</p><div class=\"tiny-share-widget\" data-id=\"1023041\" data-linked=\"Tesla Motors (NASDAQ:TSLA) gains 6.2% in premarket trading to reach $93.10 as its dizzying...\" data-tweet=\"$TSLA - Tesla Motors (NASDAQ:TSLA) gains 6.2% in premarket trading to reach $93.10 as its dizzying post-earnings victory lap continues. Morgan Stanley is out with what is largely a cautionary note before crunching the numbers for the &quot;extreme&quot; bull case... https://seekingalpha.com/news/1023041?source=tweet\" data-url=\"https://seekingalpha.com/news/1023041\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>76&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"1023011\" data-ts=\"1368531043\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CREE\" target=\"_blank\">CREE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/1023011\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cree (NASDAQ:CREE) is downgraded to Hold at Sterne Agee with price target lowered to $59. Shares...</a></h4><p>Cree (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CREE\" title=\"Cree, Inc.\">CREE</a>) is downgraded to Hold at Sterne Agee with price target lowered to $59. Shares <font color=\"red\">-2.9%</font> premarket.</p><div class=\"tiny-share-widget\" data-id=\"1023011\" data-linked=\"Cree (NASDAQ:CREE) is downgraded to Hold at Sterne Agee with price target lowered to $59. Shares...\" data-tweet=\"$CREE - Cree (NASDAQ:CREE) is downgraded to Hold at Sterne Agee with price target lowered to $59. Shares -2.9% premarket. https://seekingalpha.com/news/1023011?source=tweet\" data-url=\"https://seekingalpha.com/news/1023011\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li>","count":67,"message":null,"success":true,"today":{"start":1576818000,"end":1576904399,"str":"Friday, December 20, 2019"},"yesterday":{"start":1576731600,"end":1576817999}}